FHIR CI-Build
TerminologyThis is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions 
| Community Based Collaborative Care Work Group |
Maturity Level: 1 | Draft | Use Context: Country: World, Not Intended for Production use |
Official URL: http://hl7.org/fhir/ValueSet/consent-content-code
|
Version: 6.0.0-ballot2 | |||
| draft as of 2024-11-07 | Computable Name: ConsentContentCodes | |||
| Flags: Experimental | OID: 2.16.840.1.113883.4.642.3.748 | |||
This value set is used in the following places:
This example value set contains all LOINC code
Generated Narrative: ValueSet consent-content-code
Last updated: 2024-11-07T02:18:20.652Z
Profile: Shareable ValueSet
This value set includes codes based on the following rules:
http://loinc.org This value set excludes codes based on the following rules:
http://loinc.org where SCALE_TYP = LP32888-7 (Doc)
This expansion generated 07 Nov 2024
Generated Narrative: ValueSet
Last updated: 2024-09-22T00:44:26.61-04:00
Profile: Shareable ValueSet
Expansion based on Loinc v2.78
This value set has 190,712 codes in it. In order to keep the publication size manageable, only a selection (1,000 codes) of the whole set of codes is shown.
| Code | System | Display |
| 100000-9 |
http://loinc.org | Health informatics pioneer and the father of LOINC |
| 100001-7 |
http://loinc.org | Health informatics pioneer and cofounder of LOINC |
| 100002-5 |
http://loinc.org | Specimen care is maintained |
| 100003-3 |
http://loinc.org | Team communication is maintained throughout care |
| 100004-1 |
http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure |
| 100005-8 |
http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure |
| 100006-6 |
http://loinc.org | Demonstrates knowledge of medication management |
| 100007-4 |
http://loinc.org | Demonstrates knowledge of pain management |
| 10000-8 |
http://loinc.org | R wave duration in lead AVR |
| 100008-2 |
http://loinc.org | Demonstrates knowledge of wound management |
| 100009-0 |
http://loinc.org | Demonstrates knowledge of the procedure and expected results |
| 100010-8 |
http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation |
| 100011-6 |
http://loinc.org | No injury related to an electrical source |
| 100012-4 |
http://loinc.org | Participates in decisions affecting the patient's plan of care |
| 100013-2 |
http://loinc.org | Participates in the discharge process |
| 100014-0 |
http://loinc.org | Psychosocial health is maintained at or improved from baseline |
| 100015-7 |
http://loinc.org | No injury related to positioning due to care or procedure |
| 10001-6 |
http://loinc.org | R wave duration in lead I |
| 100016-5 |
http://loinc.org | No injury related to a laser source |
| 100017-3 |
http://loinc.org | Perioperative nursing data set outcomes panel [PNDS] |
| 100019-9 |
http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100020-7 |
http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100021-5 |
http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100022-3 |
http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100023-1 |
http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 10002-4 |
http://loinc.org | R wave duration in lead II |
| 100024-9 |
http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100025-6 |
http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100026-4 |
http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100027-2 |
http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100028-0 |
http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
| 100030-6 |
http://loinc.org | Axis I: Temporal aspects score [Mainz Pain Staging System] |
| 100031-4 |
http://loinc.org | Axis II: Spatial aspects score [Mainz Pain Staging System] |
| 10003-2 |
http://loinc.org | R wave duration in lead III |
| 100032-2 |
http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
| 100033-0 |
http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
| 100034-8 |
http://loinc.org | Provider of automated external defibrillator use |
| 100035-5 |
http://loinc.org | Exam finding location of Chest |
| 100036-3 |
http://loinc.org | Exam finding location of Lung |
| 100037-1 |
http://loinc.org | Patient contact disposition EMS unit |
| 100038-9 |
http://loinc.org | Patient evaluation disposition EMS unit |
| 100039-7 |
http://loinc.org | Crew disposition for patient care EMS unit |
| 10004-0 |
http://loinc.org | R wave duration in lead V1 |
| 100040-5 |
http://loinc.org | Patient transport disposition EMS unit |
| 100041-3 |
http://loinc.org | Aminoglycoside [Susceptibility] |
| 100042-1 |
http://loinc.org | Atovaquone [Susceptibility] |
| 100043-9 |
http://loinc.org | Azithromycin+Ethambutol [Susceptibility] |
| 100044-7 |
http://loinc.org | Cefcapene [Susceptibility] |
| 100045-4 |
http://loinc.org | Cefozopran [Susceptibility] |
| 100046-2 |
http://loinc.org | Cefquinome [Susceptibility] |
| 100047-0 |
http://loinc.org | Cefteram [Susceptibility] |
| 100048-8 |
http://loinc.org | Clarithromycin+Ethambutol [Susceptibility] |
| 100049-6 |
http://loinc.org | Eravacycline [Susceptibility] |
| 100050-4 |
http://loinc.org | Erythromycin+Ethambutol [Susceptibility] |
| 100051-2 |
http://loinc.org | Ethambutol+rifAMPin [Susceptibility] |
| 100052-0 |
http://loinc.org | Flomoxef [Susceptibility] |
| 100053-8 |
http://loinc.org | Fluoroquinolone [Susceptibility] |
| 100054-6 |
http://loinc.org | Gamithromycin [Susceptibility] |
| 100055-3 |
http://loinc.org | Optochin [Susceptibility] |
| 100056-1 |
http://loinc.org | Panipenem [Susceptibility] |
| 10005-7 |
http://loinc.org | R wave duration in lead V2 |
| 100057-9 |
http://loinc.org | Prothionamide [Susceptibility] |
| 100058-7 |
http://loinc.org | Prulifloxacin [Susceptibility] |
| 100059-5 |
http://loinc.org | Rifapentine [Susceptibility] |
| 100060-3 |
http://loinc.org | Tildipirosin [Susceptibility] |
| 100061-1 |
http://loinc.org | Tosufloxacin [Susceptibility] |
| 100062-9 |
http://loinc.org | Standard Dermatology Outcome Measures panel |
| 100063-7 |
http://loinc.org | Primary skin concern |
| 100064-5 |
http://loinc.org | Itch severity Reporting Period - Reported |
| 10006-5 |
http://loinc.org | R wave duration in lead V3 |
| 100065-2 |
http://loinc.org | Satisfied with treatment |
| 100066-0 |
http://loinc.org | Specular microscopy panel |
| 100067-8 |
http://loinc.org | Eye Image magnification |
| 100068-6 |
http://loinc.org | Right eye Fixation point [Angle] |
| 100069-4 |
http://loinc.org | Left eye Fixation point [Angle] |
| 100070-2 |
http://loinc.org | Right cornea Cell density |
| 100071-0 |
http://loinc.org | Left cornea Cell density |
| 100072-8 |
http://loinc.org | Right cornea Coefficient of variation |
| 10007-3 |
http://loinc.org | R wave duration in lead V4 |
| 100073-6 |
http://loinc.org | Left cornea Coefficient of variation |
| 100074-4 |
http://loinc.org | Right cornea Hexagonality |
| 100075-1 |
http://loinc.org | Left cornea Hexagonality |
| 100076-9 |
http://loinc.org | Right cornea Endothelial cells counted |
| 100077-7 |
http://loinc.org | Left cornea Endothelial cells counted |
| 100078-5 |
http://loinc.org | Right cornea Endothelial cell area.min |
| 100079-3 |
http://loinc.org | Left cornea Endothelial cell area.min |
| 100080-1 |
http://loinc.org | Right cornea Endothelial cell area.max |
| 10008-1 |
http://loinc.org | R wave duration in lead V5 |
| 100081-9 |
http://loinc.org | Left cornea Endothelial cell area.max |
| 100082-7 |
http://loinc.org | Right cornea Endothelial cell area.mean |
| 100083-5 |
http://loinc.org | Left cornea Endothelial cell area.mean |
| 100084-3 |
http://loinc.org | Right cornea Cell area.standard deviation |
| 100085-0 |
http://loinc.org | Left cornea Cell area.standard deviation |
| 100086-8 |
http://loinc.org | Right cornea Type of Analysis method by Specular microscopy |
| 100087-6 |
http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
| 100088-4 |
http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot |
| 100089-2 |
http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
| 1000-9 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
| 100090-0 |
http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
| 100091-8 |
http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
| 100092-6 |
http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
| 100093-4 |
http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100094-2 |
http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
| 100095-9 |
http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100096-7 |
http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100097-5 |
http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
| 100098-3 |
http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
| 10009-9 |
http://loinc.org | R wave duration in lead V6 |
| 100099-1 |
http://loinc.org | Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot |
| 100100-7 |
http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
| 100101-5 |
http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
| 100102-3 |
http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
| 100103-1 |
http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
| 100104-9 |
http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
| 100105-6 |
http://loinc.org | Filaria IgG and IgM panel - Serum |
| 100106-4 |
http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay |
| 10010-7 |
http://loinc.org | R' wave amplitude in lead AVF |
| 100107-2 |
http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
| 100108-0 |
http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
| 100109-8 |
http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot |
| 100110-6 |
http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
| 100111-4 |
http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
| 100112-2 |
http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot |
| 100113-0 |
http://loinc.org | Helicobacter pylori Ab panel - Serum |
| 100114-8 |
http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
| 10011-5 |
http://loinc.org | R' wave amplitude in lead AVL |
| 100115-5 |
http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
| 100116-3 |
http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
| 100117-1 |
http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
| 100118-9 |
http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
| 100119-7 |
http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
| 100120-5 |
http://loinc.org | Chlamydia trachomatis Ab panel - Serum |
| 100121-3 |
http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
| 100122-1 |
http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum |
| 10012-3 |
http://loinc.org | R' wave amplitude in lead AVR |
| 100123-9 |
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
| 100124-7 |
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
| 100125-4 |
http://loinc.org | Chlamydophila psittaci Ab panel - Serum |
| 100126-2 |
http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum |
| 100127-0 |
http://loinc.org | Campylobacter sp Ab panel - Serum |
| 100128-8 |
http://loinc.org | Cryptococcus sp Ag panel - Serum |
| 100129-6 |
http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
| 100130-4 |
http://loinc.org | Schistosoma mansoni Ab [Presence] in Serum by Immunoblot |
| 10013-1 |
http://loinc.org | R' wave amplitude in lead I |
| 100131-2 |
http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
| 100132-0 |
http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
| 100133-8 |
http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
| 100134-6 |
http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
| 100135-3 |
http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
| 100136-1 |
http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
| 100137-9 |
http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
| 100138-7 |
http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
| 100139-5 |
http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
| 100140-3 |
http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
| 100141-1 |
http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
| 100142-9 |
http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
| 100143-7 |
http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
| 100144-5 |
http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
| 100145-2 |
http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
| 100146-0 |
http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
| 100147-8 |
http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
| 100148-6 |
http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot |
| 10014-9 |
http://loinc.org | R' wave amplitude in lead II |
| 100149-4 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma |
| 100150-2 |
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
| 100151-0 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
| 100152-8 |
http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100153-6 |
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
| 100154-4 |
http://loinc.org | Specimen collection supervision level |
| 100155-1 |
http://loinc.org | Left cornea Type of Analysis method by Specular microscopy |
| 10015-6 |
http://loinc.org | R' wave amplitude in lead III |
| 100156-9 |
http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
| 100157-7 |
http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
| 100158-5 |
http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
| 100159-3 |
http://loinc.org | Knee Society Score pre-op panel [Knee Society Score] |
| 100160-1 |
http://loinc.org | Knee replacement |
| 100161-9 |
http://loinc.org | Charnley Functional Classification |
| 100162-7 |
http://loinc.org | Knee alignment W standing X-ray measured |
| 100163-5 |
http://loinc.org | Knee medial AndOr lateral instability W full extension |
| 10016-4 |
http://loinc.org | R' wave amplitude in lead V1 |
| 100164-3 |
http://loinc.org | Knee AP instability W 90 degree flexion |
| 100165-0 |
http://loinc.org | Knee range of motion |
| 100166-8 |
http://loinc.org | Flexion contracture range of Knee |
| 100167-6 |
http://loinc.org | Extensor lag range of Knee |
| 100168-4 |
http://loinc.org | Knee pain severity with level walking |
| 100169-2 |
http://loinc.org | Knee pain severity with stairs or inclines |
| 1001-7 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma from Donor |
| 100170-0 |
http://loinc.org | Knee feels normal |
| 100171-8 |
http://loinc.org | Satisfaction with level of knee pain while sitting |
| 10017-2 |
http://loinc.org | R' wave amplitude in lead V2 |
| 100172-6 |
http://loinc.org | Satisfaction with level of knee pain while lying in bed |
| 100173-4 |
http://loinc.org | Satisfaction with knee function while getting out of bed |
| 100174-2 |
http://loinc.org | Satisfaction with knee function while performing light household duties |
| 100175-9 |
http://loinc.org | Satisfaction with knee function while performing recreational activities |
| 100176-7 |
http://loinc.org | Expect surgery to relieve pain |
| 100177-5 |
http://loinc.org | Expect surgery will improve ability to perform activities of daily living |
| 100178-3 |
http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities |
| 100179-1 |
http://loinc.org | Walk without assistive mobility devices |
| 10018-0 |
http://loinc.org | R' wave amplitude in lead V3 |
| 100180-9 |
http://loinc.org | Assistive mobility devices used |
| 100181-7 |
http://loinc.org | Assistive mobility devices used due to health condition |
| 100182-5 |
http://loinc.org | Duration of standing before sitting due to knee discomfort |
| 100183-3 |
http://loinc.org | Duration of walking before stopping due to knee discomfort |
| 100184-1 |
http://loinc.org | How bothersome is knee when walking on an uneven surface |
| 100185-8 |
http://loinc.org | How bothersome is knee when turning or pivoting leg |
| 100186-6 |
http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs |
| 100187-4 |
http://loinc.org | How bothersome is knee when getting up from a low seat without armrests |
| 100188-2 |
http://loinc.org | How bothersome is knee when getting into or out of a car |
| 100189-0 |
http://loinc.org | How bothersome is knee when moving laterally |
| 100190-8 |
http://loinc.org | How bothersome is knee when climbing a ladder or step stool |
| 100191-6 |
http://loinc.org | How bothersome is knee when carrying a bag for one block |
| 100192-4 |
http://loinc.org | How bothersome is knee when squatting |
| 100193-2 |
http://loinc.org | How bothersome is knee when kneeling |
| 100194-0 |
http://loinc.org | How bothersome is knee when running |
| 100195-7 |
http://loinc.org | Pain severity--during activity |
| 100196-5 |
http://loinc.org | Pre-op total score [Knee Society Score] |
| 100197-3 |
http://loinc.org | Exercise activity and pain severity panel |
| 10019-8 |
http://loinc.org | R' wave amplitude in lead V4 |
| 100198-1 |
http://loinc.org | Pre-op objective knee indicators score [Knee Society Score] |
| 100199-9 |
http://loinc.org | Pre-op symptoms score [Knee Society Score] |
| 100200-5 |
http://loinc.org | Pre-op patient expectations score [Knee Society Score] |
| 100201-3 |
http://loinc.org | Pre-op functional activities score [Knee Society Score] |
| 100202-1 |
http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score] |
| 100203-9 |
http://loinc.org | Knee Society Score post-op panel [Knee Society Score] |
| 100204-7 |
http://loinc.org | Accuracy of pre-surgery expectations of pain relief |
| 100205-4 |
http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living |
| 10020-6 |
http://loinc.org | R' wave amplitude in lead V5 |
| 100206-2 |
http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |
| 100207-0 |
http://loinc.org | Post-op total score [Knee Society Score] |
| 100208-8 |
http://loinc.org | Post-op objective knee indicators score [Knee Society Score] |
| 100209-6 |
http://loinc.org | Post-op symptoms score [Knee Society Score] |
| 100210-4 |
http://loinc.org | Post-op patient expectations score [Knee Society Score] |
| 100211-2 |
http://loinc.org | Post-op functional activities score [Knee Society Score] |
| 100212-0 |
http://loinc.org | Post-op discretionary knee activities score [Knee Society Score] |
| 10021-4 |
http://loinc.org | R' wave amplitude in lead V6 |
| 100216-1 |
http://loinc.org | Surgical synoptic report |
| 100217-9 |
http://loinc.org | Synoptic report Narrative Surgical oncology |
| 100218-7 |
http://loinc.org | Surgical oncology of colon cancer synoptic report |
| 100219-5 |
http://loinc.org | Surgical oncology of melanoma cancer synoptic report |
| 100220-3 |
http://loinc.org | Surgical oncology of breast cancer synoptic report |
| 100221-1 |
http://loinc.org | Surgical oncology of thyroid cancer synoptic report |
| 10022-2 |
http://loinc.org | R' wave duration in lead AVF |
| 100222-9 |
http://loinc.org | Surgical oncology of pancreas cancer synoptic report |
| 100223-7 |
http://loinc.org | Physical findings of Retina Narrative |
| 100224-5 |
http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel |
| 10023-0 |
http://loinc.org | R' wave duration in lead AVL |
| 100230-2 |
http://loinc.org | Routine prenatal assessment panel |
| 100232-8 |
http://loinc.org | Impacts of Events Scale-Revised panel |
| 100233-6 |
http://loinc.org | Reminders brought back feelings about adverse event |
| 100234-4 |
http://loinc.org | Trouble staying asleep |
| 100235-1 |
http://loinc.org | Other things triggered persistent thoughts about adverse event |
| 100236-9 |
http://loinc.org | Felt irritable AndOr angry |
| 100237-7 |
http://loinc.org | Avoided getting upset when unintentionally thought about adverse event |
| 100238-5 |
http://loinc.org | Thought about adverse event unintentionally |
| 100239-3 |
http://loinc.org | Felt as if adverse event did not happen |
| 100240-1 |
http://loinc.org | Avoided reminders of adverse event |
| 100241-9 |
http://loinc.org | Experienced mental images of adverse event |
| 100242-7 |
http://loinc.org | Easily startled |
| 100243-5 |
http://loinc.org | Tried to not think of adverse event |
| 100244-3 |
http://loinc.org | Aware of feelings about adverse event, but did not address them |
| 100245-0 |
http://loinc.org | Feelings about adverse event were numb |
| 100246-8 |
http://loinc.org | Acted or felt the same as during adverse event |
| 100247-6 |
http://loinc.org | Trouble falling asleep |
| 10024-8 |
http://loinc.org | R' wave duration in lead AVR |
| 100248-4 |
http://loinc.org | Waves of strong feelings about adverse event |
| 100249-2 |
http://loinc.org | Tried to remove adverse event from memory |
| 1002-5 |
http://loinc.org | DBG Ab [Presence] in Serum or Plasma |
| 100250-0 |
http://loinc.org | Trouble concentrating |
| 100251-8 |
http://loinc.org | Reminders of adverse event caused physical reactions |
| 100252-6 |
http://loinc.org | Had dreams about adverse event |
| 100253-4 |
http://loinc.org | Felt watchful and on-guard |
| 100254-2 |
http://loinc.org | Tried not to talk about adverse event |
| 10025-5 |
http://loinc.org | R' wave duration in lead I |
| 100255-9 |
http://loinc.org | Total score [Impact of Event Scale-Revised] |
| 100256-7 |
http://loinc.org | Fallen in last 6 months |
| 100257-5 |
http://loinc.org | Feel unsteady when standing or walking |
| 100258-3 |
http://loinc.org | History of fall related injury |
| 100259-1 |
http://loinc.org | Aware of tactile sensations |
| 100260-9 |
http://loinc.org | Easy to describe thoughts AndOr feelings |
| 100261-7 |
http://loinc.org | Critical of own thoughts AndOr feelings |
| 100262-5 |
http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react |
| 10026-3 |
http://loinc.org | R' wave duration in lead II |
| 100263-3 |
http://loinc.org | Easily distracted |
| 100264-1 |
http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed |
| 100265-8 |
http://loinc.org | Aware of dietary intake impact on self |
| 100266-6 |
http://loinc.org | Difficult to describe thoughts AndOr feelings |
| 100267-4 |
http://loinc.org | Aware of auditory stimuli |
| 100268-2 |
http://loinc.org | Able to avoid immediate reaction in difficult situations |
| 100269-0 |
http://loinc.org | Do things without paying attention |
| 100270-8 |
http://loinc.org | Recover quickly from distressing thoughts AndOr images |
| 10027-1 |
http://loinc.org | R' wave duration in lead III |
| 100271-6 |
http://loinc.org | Aware of olfactory stimuli |
| 100272-4 |
http://loinc.org | Aware of visual stimuli |
| 100273-2 |
http://loinc.org | Aware of emotions affect on thoughts AndOr behavior |
| 100274-0 |
http://loinc.org | Observing score [FFMQ] |
| 100275-7 |
http://loinc.org | Describing score [FFMQ] |
| 100276-5 |
http://loinc.org | Acting with awareness score [FFMQ] |
| 100277-3 |
http://loinc.org | Nonjudging score [FFMQ] |
| 100278-1 |
http://loinc.org | Nonreactivity score [FFMQ] |
| 100279-9 |
http://loinc.org | Total score [FFMQ] |
| 100280-7 |
http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ] |
| 100281-5 |
http://loinc.org | D Ab [Units/volume] in Serum or Plasma |
| 100283-1 |
http://loinc.org | Harris Hip Score panel [Harris Hip Score] |
| 100284-9 |
http://loinc.org | Walking - functional ability |
| 100285-6 |
http://loinc.org | Comfortable seated position |
| 100286-4 |
http://loinc.org | Able to board public transportation |
| 100287-2 |
http://loinc.org | Put on shoes and socks |
| 100288-0 |
http://loinc.org | Absence of deformity score [Harris Hip Score] |
| 10028-9 |
http://loinc.org | R' wave duration in lead V1 |
| 100289-8 |
http://loinc.org | Absence of hip deformity measurements |
| 100290-6 |
http://loinc.org | Range of motion score [Harris Hip Score] |
| 100291-4 |
http://loinc.org | Total score [Harris Hip Score] |
| 100292-2 |
http://loinc.org | Pre-op patient satisfaction score [Knee Society Score] |
| 100293-0 |
http://loinc.org | Hip Flexion range of motion |
| 100294-8 |
http://loinc.org | Hip Abduction range of motion |
| 100295-5 |
http://loinc.org | Hip Adduction range of motion |
| 100296-3 |
http://loinc.org | Hip External rotation range of motion |
| 10029-7 |
http://loinc.org | R' wave duration in lead V2 |
| 100297-1 |
http://loinc.org | Hip Internal rotation range of motion |
| 100298-9 |
http://loinc.org | Repetition count |
| 100299-7 |
http://loinc.org | Post-op patient satisfaction score [Knee Society Score] |
| 100300-3 |
http://loinc.org | End time Unspecified body region |
| 100301-1 |
http://loinc.org | Start time Unspecified body region |
| 100302-9 |
http://loinc.org | Time period start and end panel Unspecified body region |
| 100303-7 |
http://loinc.org | Condition certainty of presence |
| 100304-5 |
http://loinc.org | Flights climbed [#] Reporting Period |
| 10030-5 |
http://loinc.org | R' wave duration in lead V3 |
| 100305-2 |
http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 100306-0 |
http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
| 100307-8 |
http://loinc.org | Behavioral screening elder mistreatment |
| 100308-6 |
http://loinc.org | Need help getting to essential places |
| 100309-4 |
http://loinc.org | Activity support person |
| 100310-2 |
http://loinc.org | Reliability of support person |
| 100311-0 |
http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house |
| 100312-8 |
http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house |
| 10031-3 |
http://loinc.org | R' wave duration in lead V4 |
| 100313-6 |
http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day |
| 100314-4 |
http://loinc.org | Need help with house cleaning or yard work |
| 100315-1 |
http://loinc.org | Need help getting out of bed, showered, or dressed |
| 100316-9 |
http://loinc.org | Need help to make sure bills get paid |
| 100317-7 |
http://loinc.org | Relationship of usual support person for daily activities |
| 100318-5 |
http://loinc.org | Have help with finances AndOr financial decisions |
| 100319-3 |
http://loinc.org | Relationship of financial support person |
| 100320-1 |
http://loinc.org | Financial support person usually asks for permission before making decisions |
| 10032-1 |
http://loinc.org | R' wave duration in lead V5 |
| 100321-9 |
http://loinc.org | Financial support person usually makes good decisions about finances |
| 100322-7 |
http://loinc.org | Have access to paperwork for financial decisions made |
| 100323-5 |
http://loinc.org | Financial support person forged signature |
| 100324-3 |
http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions |
| 100325-0 |
http://loinc.org | Experienced theft by support person |
| 100326-8 |
http://loinc.org | Money spent or property sold without permission |
| 100327-6 |
http://loinc.org | Stranger forged signature for financial gain |
| 100328-4 |
http://loinc.org | Stranger forced document signature for financial gain |
| 100329-2 |
http://loinc.org | Feared for safety due to verbal attack |
| 1003-3 |
http://loinc.org | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
| 100330-0 |
http://loinc.org | Felt humiliated due to ridicule |
| 100331-8 |
http://loinc.org | Coerced to do something |
| 100332-6 |
http://loinc.org | Ignored by close friend or relative for extended period |
| 100333-4 |
http://loinc.org | Physically hit or threatened |
| 100334-2 |
http://loinc.org | Been physically hurt with some degree of injury |
| 100335-9 |
http://loinc.org | Coerced sexual activity |
| 100336-7 |
http://loinc.org | Coerced touching of private body parts of self or others |
| 100337-5 |
http://loinc.org | Coerced to undress or expose private body area |
| 100338-3 |
http://loinc.org | Photographed in any degree of nudity without consent |
| 10033-9 |
http://loinc.org | R' wave duration in lead V6 |
| 100339-1 |
http://loinc.org | Experienced attempted physical restraint |
| 100340-9 |
http://loinc.org | Range of motion panel Hip |
| 100341-7 |
http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
| 100342-5 |
http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
| 100343-3 |
http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 100344-1 |
http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
| 100345-8 |
http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
| 100346-6 |
http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
| 10034-7 |
http://loinc.org | S wave amplitude in lead AVF |
| 100347-4 |
http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
| 100348-2 |
http://loinc.org | Model for end-stage liver disease sodium score |
| 100350-8 |
http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
| 100351-6 |
http://loinc.org | Pioglitazone [Presence] in Serum or Plasma |
| 100352-4 |
http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma |
| 100353-2 |
http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC] |
| 10035-4 |
http://loinc.org | S wave amplitude in lead AVL |
| 100354-0 |
http://loinc.org | Frequency of participating in multi-modal communication without assistance |
| 100355-7 |
http://loinc.org | Frequency of participating in spoken language expression communication without assistance |
| 100356-5 |
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
| 100357-3 |
http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method |
| 100358-1 |
http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method |
| 100359-9 |
http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
| 100360-7 |
http://loinc.org | Brief Resilience Scale panel [BRS] |
| 100361-5 |
http://loinc.org | Quickly recover from bad events |
| 10036-2 |
http://loinc.org | S wave amplitude in lead AVR |
| 100362-3 |
http://loinc.org | Difficulty making it through stressful events |
| 100363-1 |
http://loinc.org | Easily recover from a stressful event |
| 100364-9 |
http://loinc.org | Difficulty recovering from bad events |
| 100365-6 |
http://loinc.org | Easily recover from difficulties |
| 100366-4 |
http://loinc.org | Lengthy recovery from setbacks |
| 100367-2 |
http://loinc.org | Total Score BRS |
| 100368-0 |
http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
| 10037-0 |
http://loinc.org | S wave amplitude in lead I |
| 100370-6 |
http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
| 100371-4 |
http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay |
| 100372-2 |
http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma |
| 100373-0 |
http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum |
| 100374-8 |
http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum |
| 100375-5 |
http://loinc.org | Anise IgG Ab [Units/volume] in Serum |
| 100376-3 |
http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
| 100377-1 |
http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum |
| 100378-9 |
http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum |
| 100379-7 |
http://loinc.org | Leeks IgG Ab [Units/volume] in Serum |
| 100380-5 |
http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum |
| 100381-3 |
http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
| 100382-1 |
http://loinc.org | FDA package insert REMS addressed risk |
| 100383-9 |
http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
| 100384-7 |
http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum |
| 100385-4 |
http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum |
| 100386-2 |
http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum |
| 100387-0 |
http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum |
| 10038-8 |
http://loinc.org | S wave amplitude in lead II |
| 100388-8 |
http://loinc.org | Cocoa IgG Ab [Units/volume] in Serum |
| 100389-6 |
http://loinc.org | Pistachio IgG Ab [Units/volume] in Serum |
| 100390-4 |
http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum |
| 100391-2 |
http://loinc.org | Dates IgG Ab [Units/volume] in Serum |
| 100392-0 |
http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum |
| 100393-8 |
http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
| 100394-6 |
http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum |
| 100395-3 |
http://loinc.org | Carob IgG Ab [Units/volume] in Serum |
| 10039-6 |
http://loinc.org | S wave amplitude in lead III |
| 100396-1 |
http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum |
| 100397-9 |
http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum |
| 100398-7 |
http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum |
| 100399-5 |
http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum |
| 100400-1 |
http://loinc.org | Quail meat IgG Ab [Units/volume] in Serum |
| 100401-9 |
http://loinc.org | Rabbit meat IgG Ab [Units/volume] in Serum |
| 100402-7 |
http://loinc.org | Venison meat IgG Ab [Units/volume] in Serum |
| 100403-5 |
http://loinc.org | Guineafowl IgG Ab [Units/volume] in Serum |
| 10040-4 |
http://loinc.org | S wave amplitude in lead V1 |
| 100404-3 |
http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum |
| 100405-0 |
http://loinc.org | Kefir IgG Ab [Units/volume] in Serum |
| 100406-8 |
http://loinc.org | Butter IgG Ab [Units/volume] in Serum |
| 100407-6 |
http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum |
| 100408-4 |
http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum |
| 100409-2 |
http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum |
| 1004-1 |
http://loinc.org | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
| 100410-0 |
http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum |
| 100411-8 |
http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum |
| 10041-2 |
http://loinc.org | S wave amplitude in lead V2 |
| 100412-6 |
http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum |
| 100413-4 |
http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum |
| 100414-2 |
http://loinc.org | Gourd IgG Ab [Units/volume] in Serum |
| 100415-9 |
http://loinc.org | Kale IgG Ab [Units/volume] in Serum |
| 100416-7 |
http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum |
| 100417-5 |
http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum |
| 100418-3 |
http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum |
| 100419-1 |
http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum |
| 10042-0 |
http://loinc.org | S wave amplitude in lead V3 |
| 100420-9 |
http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum |
| 100421-7 |
http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum |
| 100422-5 |
http://loinc.org | Chicory IgG Ab [Units/volume] in Serum |
| 100423-3 |
http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
| 100424-1 |
http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
| 100425-8 |
http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
| 100426-6 |
http://loinc.org | Squalene [Mass/volume] in Serum or Plasma |
| 100427-4 |
http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma |
| 100428-2 |
http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine |
| 100429-0 |
http://loinc.org | LRBA deficiency panel - Blood |
| 100430-8 |
http://loinc.org | Cells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC) |
| 100431-6 |
http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 100432-4 |
http://loinc.org | Cells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC) |
| 100433-2 |
http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
| 100434-0 |
http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
| 100435-7 |
http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
| 100436-5 |
http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
| 100437-3 |
http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
| 10043-8 |
http://loinc.org | S wave amplitude in lead V4 |
| 10044-6 |
http://loinc.org | S wave amplitude in lead V5 |
| 10045-3 |
http://loinc.org | S wave amplitude in lead V6 |
| 10046-1 |
http://loinc.org | S wave duration in lead AVF |
| 10047-9 |
http://loinc.org | S wave duration in lead AVL |
| 10048-7 |
http://loinc.org | S wave duration in lead AVR |
| 10049-5 |
http://loinc.org | S wave duration in lead I |
| 10050-3 |
http://loinc.org | S wave duration in lead II |
| 10051-1 |
http://loinc.org | S wave duration in lead III |
| 10052-9 |
http://loinc.org | S wave duration in lead V1 |
| 10053-7 |
http://loinc.org | S wave duration in lead V2 |
| 10054-5 |
http://loinc.org | S wave duration in lead V3 |
| 10055-2 |
http://loinc.org | S wave duration in lead V4 |
| 10056-0 |
http://loinc.org | S wave duration in lead V5 |
| 10057-8 |
http://loinc.org | S wave duration in lead V6 |
| 1005-8 |
http://loinc.org | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
| 10058-6 |
http://loinc.org | S' wave amplitude in lead AVF |
| 10059-4 |
http://loinc.org | S' wave amplitude in lead AVL |
| 10060-2 |
http://loinc.org | S' wave amplitude in lead AVR |
| 10061-0 |
http://loinc.org | S' wave amplitude in lead I |
| 10062-8 |
http://loinc.org | S' wave amplitude in lead II |
| 10063-6 |
http://loinc.org | S' wave amplitude in lead III |
| 10064-4 |
http://loinc.org | S' wave amplitude in lead V1 |
| 10065-1 |
http://loinc.org | S' wave amplitude in lead V2 |
| 100652-7 |
http://loinc.org | Pure tone bone conduction threshold audiometry panel |
| 100653-5 |
http://loinc.org | Pure tone air conduction threshold audiometry panel |
| 100654-3 |
http://loinc.org | Pyruvate kinase M2 [Presence] in Stool |
| 1006-6 |
http://loinc.org | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
| 100662-6 |
http://loinc.org | Cortisol free and total panel - Serum or Plasma |
| 100663-4 |
http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
| 100664-2 |
http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
| 100665-9 |
http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
| 100666-7 |
http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
| 100667-5 |
http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
| 100668-3 |
http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
| 10066-9 |
http://loinc.org | S' wave amplitude in lead V3 |
| 100669-1 |
http://loinc.org | NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
| 100670-9 |
http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
| 100671-7 |
http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
| 100672-5 |
http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
| 100673-3 |
http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
| 100674-1 |
http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100675-8 |
http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
| 100676-6 |
http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
| 10067-7 |
http://loinc.org | S' wave amplitude in lead V4 |
| 100677-4 |
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100678-2 |
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100679-0 |
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100680-8 |
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100681-6 |
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100682-4 |
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100683-2 |
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100684-0 |
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 10068-5 |
http://loinc.org | S' wave amplitude in lead V5 |
| 100685-7 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
| 100686-5 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 100687-3 |
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
| 100688-1 |
http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100689-9 |
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
| 100690-7 |
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
| 100691-5 |
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
| 100692-3 |
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 10069-3 |
http://loinc.org | S' wave amplitude in lead V6 |
| 100693-1 |
http://loinc.org | Pneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection |
| 100694-9 |
http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
| 100695-6 |
http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
| 100696-4 |
http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
| 100699-8 |
http://loinc.org | Rifabutin+Ethambutol [Susceptibility] |
| 100700-4 |
http://loinc.org | Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection |
| 10070-1 |
http://loinc.org | S' wave duration in lead AVF |
| 100701-2 |
http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
| 100702-0 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
| 100703-8 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
| 100704-6 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
| 100705-3 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
| 100706-1 |
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
| 100707-9 |
http://loinc.org | Polymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count |
| 100708-7 |
http://loinc.org | Plasma cells/100 leukocytes in Synovial fluid |
| 100709-5 |
http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD |
| 100710-3 |
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
| 100711-1 |
http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
| 100712-9 |
http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma |
| 100713-7 |
http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma |
| 100714-5 |
http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma |
| 100715-2 |
http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma |
| 100716-0 |
http://loinc.org | Prostate specific Ag [Mass/volume] in DBS |
| 100717-8 |
http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
| 10071-9 |
http://loinc.org | S' wave duration in lead AVL |
| 10072-7 |
http://loinc.org | S' wave duration in lead AVR |
| 100732-7 |
http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
| 100733-5 |
http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
| 100734-3 |
http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method |
| 10073-5 |
http://loinc.org | S' wave duration in lead I |
| 100735-0 |
http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
| 100737-6 |
http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
| 100738-4 |
http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 100739-2 |
http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
| 1007-4 |
http://loinc.org | Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells |
| 100740-0 |
http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma |
| 100741-8 |
http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
| 100742-6 |
http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
| 10074-3 |
http://loinc.org | S' wave duration in lead II |
| 100743-4 |
http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma |
| 100744-2 |
http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
| 100745-9 |
http://loinc.org | Chloride [Moles/volume] in Mixed venous blood |
| 100746-7 |
http://loinc.org | Glucose [Moles/volume] in Mixed venous blood |
| 100747-5 |
http://loinc.org | Legionella serogroup panel - Specimen |
| 100748-3 |
http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection |
| 100749-1 |
http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 10075-0 |
http://loinc.org | S' wave duration in lead III |
| 100750-9 |
http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
| 100751-7 |
http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
| 100752-5 |
http://loinc.org | Exacerbating factors - Reported |
| 100753-3 |
http://loinc.org | Alleviating factors - Reported |
| 100755-8 |
http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
| 100756-6 |
http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
| 100757-4 |
http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
| 100758-2 |
http://loinc.org | Estimated lung age by based on clinical data |
| 100759-0 |
http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry |
| 100762-4 |
http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
| 100763-2 |
http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative |
| 100764-0 |
http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
| 100765-7 |
http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS |
| 100766-5 |
http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D] |
| 100767-3 |
http://loinc.org | Bothered by things that are not usually bothersome |
| 10076-8 |
http://loinc.org | S' wave duration in lead V1 |
| 100768-1 |
http://loinc.org | Poor appetite |
| 100769-9 |
http://loinc.org | Unhappy even with help from my family or friends |
| 100770-7 |
http://loinc.org | Feeling just as good as others |
| 100771-5 |
http://loinc.org | Trouble focusing |
| 100772-3 |
http://loinc.org | Feeling depressed |
| 100773-1 |
http://loinc.org | Feeling everything is too much of an effort |
| 100774-9 |
http://loinc.org | Feeling hopeful about the future |
| 100775-6 |
http://loinc.org | Feeling life had been a failure |
| 10077-6 |
http://loinc.org | S' wave duration in lead V2 |
| 100776-4 |
http://loinc.org | Feeling fearful |
| 100777-2 |
http://loinc.org | Restless sleep |
| 100778-0 |
http://loinc.org | Feeling happy |
| 100779-8 |
http://loinc.org | Quieter than usual |
| 100780-6 |
http://loinc.org | Feeling lonely |
| 100781-4 |
http://loinc.org | People were unfriendly |
| 100782-2 |
http://loinc.org | Enjoying life |
| 100783-0 |
http://loinc.org | Crying spells |
| 10078-4 |
http://loinc.org | S' wave duration in lead V3 |
| 100784-8 |
http://loinc.org | Feeling sad |
| 100785-5 |
http://loinc.org | Feeling people dislike me |
| 100786-3 |
http://loinc.org | Lack of energy |
| 100787-1 |
http://loinc.org | Total Score CES-D |
| 100788-9 |
http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
| 100789-7 |
http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
| 100790-5 |
http://loinc.org | Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum |
| 100791-3 |
http://loinc.org | Hamster epithelium IgG Ab [Mass/volume] in Serum |
| 10079-2 |
http://loinc.org | S' wave duration in lead V4 |
| 100792-1 |
http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum |
| 100793-9 |
http://loinc.org | Testosterone [Mass/volume] in Body fluid |
| 100794-7 |
http://loinc.org | Follitropin [Units/volume] in Body fluid |
| 100795-4 |
http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid |
| 100796-2 |
http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid |
| 100797-0 |
http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100798-8 |
http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 100799-6 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
| 100-8 |
http://loinc.org | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
| 10080-0 |
http://loinc.org | S' wave duration in lead V5 |
| 100800-2 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
| 100801-0 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
| 100802-8 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
| 100803-6 |
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
| 100804-4 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
| 100805-1 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
| 100806-9 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
| 100807-7 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
| 100808-5 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
| 100809-3 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
| 100810-1 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
| 100811-9 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
| 100812-7 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
| 100813-5 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
| 100814-3 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
| 100815-0 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
| 100816-8 |
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 100817-6 |
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 10081-8 |
http://loinc.org | S' wave duration in lead V6 |
| 100818-4 |
http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
| 100819-2 |
http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
| 1008-2 |
http://loinc.org | Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma |
| 100820-0 |
http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
| 100821-8 |
http://loinc.org | National POLST form: portable medical order panel |
| 100822-6 |
http://loinc.org | Cardiopulmonary resuscitation orders |
| 100823-4 |
http://loinc.org | Initial portable medical treatment orders |
| 100824-2 |
http://loinc.org | Additional portable medical orders or instructions |
| 100825-9 |
http://loinc.org | Medically assisted nutrition orders |
| 10082-6 |
http://loinc.org | ST initial amplitude 6 ms in lead AVF |
| 100826-7 |
http://loinc.org | Portable medical order AndOr advance directive review |
| 100827-5 |
http://loinc.org | Portable medical order discussion participants |
| 100828-3 |
http://loinc.org | Portable medical order administrative information |
| 100829-1 |
http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
| 100830-9 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
| 100831-7 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
| 100832-5 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
| 100833-3 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
| 10083-4 |
http://loinc.org | ST initial amplitude 6 ms in lead AVL |
| 100834-1 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
| 100835-8 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
| 100836-6 |
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
| 100837-4 |
http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 100838-2 |
http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
| 100839-0 |
http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
| 100840-8 |
http://loinc.org | IgE [Units/volume] in Body fluid |
| 100841-6 |
http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
| 10084-2 |
http://loinc.org | ST initial amplitude 6 ms in lead AVR |
| 100842-4 |
http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
| 100843-2 |
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
| 100844-0 |
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
| 100845-7 |
http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
| 100846-5 |
http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 100847-3 |
http://loinc.org | Gas and ammonia panel - Arterial blood |
| 100848-1 |
http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count |
| 100849-9 |
http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count |
| 100850-7 |
http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count |
| 100851-5 |
http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count |
| 100854-9 |
http://loinc.org | Lymphocytes/100 cells in Blood mononuclear cells by Immunoassay |
| 100855-6 |
http://loinc.org | CD3 cells/100 cells in Blood mononuclear cells |
| 100856-4 |
http://loinc.org | CD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells |
| 100857-2 |
http://loinc.org | CD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells |
| 100858-0 |
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 10085-9 |
http://loinc.org | ST initial amplitude 6 ms in lead I |
| 100859-8 |
http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 100860-6 |
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
| 100861-4 |
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100862-2 |
http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100863-0 |
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
| 100864-8 |
http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
| 100865-5 |
http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
| 100866-3 |
http://loinc.org | Febrile antibody profile in Serum |
| 10086-7 |
http://loinc.org | ST initial amplitude 6 ms in lead II |
| 100867-1 |
http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
| 100868-9 |
http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
| 100869-7 |
http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
| 100870-5 |
http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
| 100871-3 |
http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
| 100872-1 |
http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
| 100873-9 |
http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
| 100874-7 |
http://loinc.org | Basidiobolus sp [Presence] in Specimen |
| 10087-5 |
http://loinc.org | ST initial amplitude 6 ms in lead III |
| 10088-3 |
http://loinc.org | ST initial amplitude 6 ms in lead V1 |
| 100885-3 |
http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
| 100886-1 |
http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
| 100887-9 |
http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
| 100888-7 |
http://loinc.org | Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection |
| 100889-5 |
http://loinc.org | Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection |
| 100890-3 |
http://loinc.org | Poxvirus DNA panel |
| 10089-1 |
http://loinc.org | ST initial amplitude 6 ms in lead V2 |
| 100891-1 |
http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
| 100892-9 |
http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
| 100893-7 |
http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
| 100894-5 |
http://loinc.org | Recommended screening frequency Narrative |
| 100895-2 |
http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
| 100896-0 |
http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
| 100897-8 |
http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
| 100898-6 |
http://loinc.org | Lipid panel - Serum or Plasma |
| 100899-4 |
http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
| 1009-0 |
http://loinc.org | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
| 100900-0 |
http://loinc.org | Enterobacteriaceae.carbapenem resistance panel - Anal by Organism specific culture |
| 100901-8 |
http://loinc.org | Enterobacteriaceae.carbapenemase resistance phenotype [Identifier] in Anal by Organism specific culture |
| 100902-6 |
http://loinc.org | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 [Identifier] in Anal by Organism specific culture |
| 100903-4 |
http://loinc.org | Yeast and Candida sp identification panel - Specimen by Organism specific culture |
| 100904-2 |
http://loinc.org | Urinary tract pathogens panel - Urine by Culture |
| 100905-9 |
http://loinc.org | Gram positive bacteria identified in Isolate by Organism specific culture |
| 100906-7 |
http://loinc.org | Bacteria [#/volume] in Urine by Culture |
| 100907-5 |
http://loinc.org | Vancomycin resistant enterococcus [Identifier] in Specimen by Organism specific culture |
| 100908-3 |
http://loinc.org | Pseudomonas aeruginosa [Presence] in Lower respiratory specimen by Organism specific culture |
| 10090-9 |
http://loinc.org | ST initial amplitude 6 ms in lead V3 |
| 100909-1 |
http://loinc.org | Cronobacter sakazakii [Presence] by Organism specific culture |
| 100910-9 |
http://loinc.org | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture |
| 100911-7 |
http://loinc.org | Campylobacter sp [Presence] in Stool by Organism specific culture |
| 100912-5 |
http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel |
| 100913-3 |
http://loinc.org | Staph aureus and MRSA screening panel - Specimen by Organism specific culture |
| 100914-1 |
http://loinc.org | Protein.abnormal band [Mass/volume] in Serum or Plasma by Electrophoresis |
| 100915-8 |
http://loinc.org | Burr cells [Presence] in Body fluid by Light microscopy |
| 100916-6 |
http://loinc.org | User satisfaction score [R-Outcomes] |
| 10091-7 |
http://loinc.org | ST initial amplitude 6 ms in lead V4 |
| 100917-4 |
http://loinc.org | Product of interest effectiveness |
| 100918-2 |
http://loinc.org | Product of interest usability |
| 100919-0 |
http://loinc.org | Access to help with product of interest |
| 100920-8 |
http://loinc.org | Satisfied with product of interest |
| 100921-6 |
http://loinc.org | User satisfaction panel [R-Outcomes] |
| 100922-4 |
http://loinc.org | Privacy panel [R-Outcomes] |
| 100923-2 |
http://loinc.org | Privacy score [R-Outcomes] |
| 100924-0 |
http://loinc.org | Safe and secure healthcare data |
| 10092-5 |
http://loinc.org | ST initial amplitude 6 ms in lead V5 |
| 100925-7 |
http://loinc.org | Healthcare data exchanged as needed |
| 100926-5 |
http://loinc.org | Access to review healthcare data |
| 100927-3 |
http://loinc.org | Satisfied with healthcare data use |
| 100928-1 |
http://loinc.org | Digital confidence panel [R-Outcomes] |
| 100929-9 |
http://loinc.org | Digital confidence score [R-Outcomes] |
| 100930-7 |
http://loinc.org | Digital device use |
| 100931-5 |
http://loinc.org | Friends use digital devices |
| 100932-3 |
http://loinc.org | Access to help with digital devices |
| 10093-3 |
http://loinc.org | ST initial amplitude 6 ms in lead V6 |
| 100933-1 |
http://loinc.org | Confident using digital devices |
| 100934-9 |
http://loinc.org | Personal safety panel [R-Outcomes] |
| 100935-6 |
http://loinc.org | Personal safety score [R-Outcomes] |
| 100936-4 |
http://loinc.org | Feel safe at home |
| 100937-2 |
http://loinc.org | Feel respected at home |
| 100938-0 |
http://loinc.org | Feel safe outside home |
| 100939-8 |
http://loinc.org | Feel respected outside home |
| 100940-6 |
http://loinc.org | Neighbor relationships panel [R-Outcomes] |
| 10094-1 |
http://loinc.org | ST slope in lead AVF |
| 100941-4 |
http://loinc.org | Neighbor relationships score [R-Outcomes] |
| 100942-2 |
http://loinc.org | Neighbors and I know each other |
| 100943-0 |
http://loinc.org | Neighbors and I trust each other |
| 100944-8 |
http://loinc.org | Neighbors and I share information |
| 100945-5 |
http://loinc.org | Neighbors and I help each other |
| 100946-3 |
http://loinc.org | Loneliness (ONS) score |
| 100947-1 |
http://loinc.org | Frequency of having no one to talk to |
| 100948-9 |
http://loinc.org | Frequency of feeling left out |
| 100949-7 |
http://loinc.org | Frequency of feeling alone |
| 100950-5 |
http://loinc.org | Frequency of feeling lonely |
| 100951-3 |
http://loinc.org | Loneliness Office of National Statistics panel |
| 100952-1 |
http://loinc.org | Product confidence panel [R-Outcomes] |
| 100953-9 |
http://loinc.org | Product confidence score [R-Outcomes] |
| 100954-7 |
http://loinc.org | Product of interest use |
| 100955-4 |
http://loinc.org | Confident using product of interest |
| 100956-2 |
http://loinc.org | Understand potential benefits of product of interest |
| 100957-0 |
http://loinc.org | Understand potential problems of product of interest |
| 10095-8 |
http://loinc.org | ST slope in lead AVL |
| 100958-8 |
http://loinc.org | Digital readiness panel [R-Outcomes] |
| 100959-6 |
http://loinc.org | Digital readiness score [R-Outcomes] |
| 100960-4 |
http://loinc.org | New ideas are needed in field of work |
| 100961-2 |
http://loinc.org | Follow new ideas in field of work |
| 100962-0 |
http://loinc.org | Dengue virus Ab.IgG Panel - Serum, Plasma or Blood |
| 100963-8 |
http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay |
| 100964-6 |
http://loinc.org | Dengue virus IgG Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
| 100965-3 |
http://loinc.org | Dengue virus IgG Ab [Interpretation] in Serum, Plasma or Blood |
| 10096-6 |
http://loinc.org | ST slope in lead AVR |
| 100968-7 |
http://loinc.org | Bovine tuberculosis comparative cervical test panel - Skin |
| 100969-5 |
http://loinc.org | Pathology report additional specified observation in Specimen Narrative |
| 100970-3 |
http://loinc.org | Portable medical order completion information |
| 100971-1 |
http://loinc.org | Clinical record panel |
| 100972-9 |
http://loinc.org | Influenza virus A and Influenza virus B and SARS coronavirus 2 RNA panel - Nose by NAA with non-probe detection |
| 100973-7 |
http://loinc.org | Influenza virus A RNA [Presence] in Nose by NAA with non-probe detection |
| 10097-4 |
http://loinc.org | ST slope in lead I |
| 100974-5 |
http://loinc.org | Influenza virus B RNA [Presence] in Nose by NAA with non-probe detection |
| 100975-2 |
http://loinc.org | Induced abortion method |
| 100976-0 |
http://loinc.org | Eosinophil derived neurotoxin [Mass/volume] in Serum or Plasma |
| 100977-8 |
http://loinc.org | JC virus Ab Index in Serum or Plasma by Immunoassay |
| 100978-6 |
http://loinc.org | Thyroxine.free.gestational [Moles/volume] in Serum or Plasma by Immunoassay |
| 100979-4 |
http://loinc.org | Atopobium vaginae DNA [Presence] in Urine by NAA with probe detection |
| 100980-2 |
http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
| 100981-0 |
http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 10098-2 |
http://loinc.org | ST slope in lead II |
| 100982-8 |
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
| 100983-6 |
http://loinc.org | HIV reverse transcriptase failed codons [Identifier] by Genotype method |
| 100984-4 |
http://loinc.org | HIV 1 group M RNA genotype [Identifier] by Genotype method |
| 100985-1 |
http://loinc.org | HIV protease failed codons [Identifier] by Genotype method |
| 100986-9 |
http://loinc.org | HIV integrase failed codons [Identifier] by Genotype method |
| 100987-7 |
http://loinc.org | Lymphocyte T-cell and B-cell and Natural killer subsets panel - Cerebral spinal fluid |
| 100988-5 |
http://loinc.org | Phosphoglucomutase [Enzymatic activity/volume] in Fibroblast |
| 100989-3 |
http://loinc.org | Phosphoglucomutase [Enzymatic activity/volume] in Leukocytes |
| 10099-0 |
http://loinc.org | ST slope in lead III |
| 100990-1 |
http://loinc.org | Fathers Blood group antigens panel |
| 100994-3 |
http://loinc.org | B-cell CD19 and CD20 subsets panel - Blood by Flow cytometry (FC) |
| 100995-0 |
http://loinc.org | Laceyella sacchari IgG Ab [Presence] in Serum |
| 100996-8 |
http://loinc.org | Neurofilament light chain [Mass/volume] in Cerebral spinal fluid |
| 100997-6 |
http://loinc.org | Respiratory Allergen Panel, Area 5 - Serum |
| 100998-4 |
http://loinc.org | Cortisol post dose insulin IV panel - Serum or Plasma |
| 100999-2 |
http://loinc.org | Somatotropin post dose insulin IV panel - Serum or Plasma |
| 101000-8 |
http://loinc.org | Health informatics leader and champion of semantic interoperability |
| 101001-6 |
http://loinc.org | Chief technical architect and steadfast leader of LOINC |
| 101002-4 |
http://loinc.org | Monkeypox virus sequencing panel - Specimen by Sequencing |
| 101003-2 |
http://loinc.org | Monkeypox virus clade [Type] in Specimen by Sequencing |
| 101004-0 |
http://loinc.org | Monkeypox virus lineage [Type] in Specimen by Sequencing |
| 10100-6 |
http://loinc.org | ST slope in lead V1 |
| 10101-4 |
http://loinc.org | ST slope in lead V2 |
| 10102-2 |
http://loinc.org | ST slope in lead V3 |
| 10103-0 |
http://loinc.org | ST slope in lead V4 |
| 10104-8 |
http://loinc.org | ST slope in lead V5 |
| 10105-5 |
http://loinc.org | ST slope in lead V6 |
| 101060-2 |
http://loinc.org | An^a Ab [Presence] in Serum or Plasma |
| 101061-0 |
http://loinc.org | Be^a Ab [Presence] in Serum or Plasma |
| 101062-8 |
http://loinc.org | BARC Ab [Presence] in Serum or Plasma |
| 10106-3 |
http://loinc.org | ST wave end displacement in lead AVF |
| 101063-6 |
http://loinc.org | Co3 Ag Ab [Presence] in Serum or Plasma |
| 101064-4 |
http://loinc.org | Co3 Ag Ag [Presence] on Red Blood Cells |
| 101065-1 |
http://loinc.org | Co4 Ab [Presence] in Serum or Plasma |
| 101066-9 |
http://loinc.org | Cr^a Ab [Presence] in Serum or Plasma |
| 101067-7 |
http://loinc.org | Cs^b Ab [Presence] in Serum or Plasma |
| 101068-5 |
http://loinc.org | Cs^b Ag [Presence] on Red Blood Cells |
| 101069-3 |
http://loinc.org | CE Ab [Presence] in Serum or Plasma |
| 101070-1 |
http://loinc.org | CEAG Ab [Presence] in Serum or Plasma |
| 10107-1 |
http://loinc.org | ST wave end displacement in lead AVL |
| 101071-9 |
http://loinc.org | CELO Ab [Presence] in Serum or Plasma |
| 101072-7 |
http://loinc.org | CENR Ab [Presence] in Serum or Plasma |
| 101073-5 |
http://loinc.org | CEST Ab [Presence] in Serum or Plasma |
| 101074-3 |
http://loinc.org | CEVF Ab [Presence] in Serum or Plasma |
| 101075-0 |
http://loinc.org | Crawford Ab [Presence] in Serum or Plasma |
| 101076-8 |
http://loinc.org | Dh^a Ab [Presence] in Serum or Plasma |
| 101077-6 |
http://loinc.org | Dr^a Ab [Presence] in Serum or Plasma |
| 101078-4 |
http://loinc.org | Dw Ab [Presence] in Serum or Plasma |
| 101079-2 |
http://loinc.org | DAK Ab [Presence] in Serum or Plasma |
| 1010-8 |
http://loinc.org | E sup(w) Ab [Presence] in Serum or Plasma from Blood product unit |
| 101080-0 |
http://loinc.org | En^a Ab [Presence] in Serum or Plasma |
| 101081-8 |
http://loinc.org | Es^a Ab [Presence] in Serum or Plasma |
| 101082-6 |
http://loinc.org | Evans Ab [Presence] in Serum or Plasma |
| 101083-4 |
http://loinc.org | Fy5 Ab [Presence] in Serum or Plasma |
| 101084-2 |
http://loinc.org | FPTT Ab [Presence] in Serum or Plasma |
| 101085-9 |
http://loinc.org | Ge1 Ab [Presence] in Serum or Plasma |
| 101086-7 |
http://loinc.org | Ge2 Ab [Presence] in Serum or Plasma |
| 101087-5 |
http://loinc.org | Ge2 Ag [Presence] on Red Blood Cells |
| 101088-3 |
http://loinc.org | Ge3 Ab [Presence] in Serum or Plasma |
| 10108-9 |
http://loinc.org | ST wave end displacement in lead AVR |
| 101089-1 |
http://loinc.org | Ge3 Ag [Presence] on Red Blood Cells |
| 101090-9 |
http://loinc.org | Ge4 Ab [Presence] in Serum or Plasma |
| 101091-7 |
http://loinc.org | Hr^s Ab [Presence] in Serum or Plasma |
| 101092-5 |
http://loinc.org | Hr^B Ab [Presence] in Serum or Plasma |
| 101093-3 |
http://loinc.org | Hut Ab [Presence] in Serum or Plasma |
| 101094-1 |
http://loinc.org | In^a Ab [Presence] in Serum or Plasma |
| 101095-8 |
http://loinc.org | IFC Ab [Presence] in Serum or Plasma |
| 101096-6 |
http://loinc.org | Jo sup(a) Ab [Presence] in Serum or Plasma |
| 10109-7 |
http://loinc.org | ST wave end displacement in lead I |
| 101097-4 |
http://loinc.org | JAHK Ab [Presence] in Serum or Plasma |
| 101098-2 |
http://loinc.org | JMH Ag [Presence] on Red Blood Cells |
| 101099-0 |
http://loinc.org | Km Ab [Presence] in Serum or Plasma |
| 101100-6 |
http://loinc.org | Ku Ag [Presence] on Red Blood Cells |
| 101101-4 |
http://loinc.org | Kx Ab [Presence] in Serum or Plasma |
| 101102-2 |
http://loinc.org | Kx Ag [Presence] on Red Blood Cells |
| 101103-0 |
http://loinc.org | C^G Ab [Presence] in Serum or Plasma |
| 101104-8 |
http://loinc.org | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 during assessment period [CMS Assessment] |
| 10110-5 |
http://loinc.org | ST wave end displacement in lead II |
| 101105-5 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] |
| 101106-3 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] |
| 101107-1 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] |
| 101108-9 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] |
| 101109-7 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] |
| 101110-5 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] |
| 101111-3 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] |
| 101112-1 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] |
| 10111-3 |
http://loinc.org | ST wave end displacement in lead III |
| 101113-9 |
http://loinc.org | MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set during assessment period [CMS Assessment] |
| 101114-7 |
http://loinc.org | NCSBN ID |
| 101115-4 |
http://loinc.org | Leukotriene E4/Creatinine [Mass Ratio] in 24 hour Urine |
| 101116-2 |
http://loinc.org | THSD7A Ag [Presence] in Tissue by Immunofluorescence |
| 101120-4 |
http://loinc.org | Candida glabrata+krusei DNA [Presence] in Blood by NAA with probe detection |
| 10112-1 |
http://loinc.org | ST wave end displacement in lead V1 |
| 101121-2 |
http://loinc.org | Candida albicans and tropicalis DNA [Presence] in Blood by NAA with probe detection |
| 101122-0 |
http://loinc.org | Mephobarbital [Mass/volume] in Blood by Confirmatory method |
| 101123-8 |
http://loinc.org | Bacterial carbapenem resistance blaIMI gene [Presence] by Molecular method |
| 101124-6 |
http://loinc.org | Bacterial carbapenem resistance blaIMI+blaNMC genes [Presence] by Molecular method |
| 101125-3 |
http://loinc.org | Bacterial carbapenem resistance blaOXA-235-like gene [Presence] by Molecular method |
| 101126-1 |
http://loinc.org | Bacterial carbapenem resistance blaOXA-24+blaOXA-40 gene [Presence] by Molecular method |
| 101127-9 |
http://loinc.org | Bacterial carbapenem resistance blaSIM gene [Presence] by Molecular method |
| 101128-7 |
http://loinc.org | Theoretical limit of detection [#] in Specimen by calculation |
| 101129-5 |
http://loinc.org | Laboratory device Assay Sensitivity |
| 101130-3 |
http://loinc.org | Mast cells/100 cells in Bone marrow by Flow cytometry (FC) |
| 101131-1 |
http://loinc.org | B-cell precursors in Bone marrow by Flow cytometry (FC) |
| 101132-9 |
http://loinc.org | Glucose post XXX challenge panel - Serum or Plasma |
| 101137-8 |
http://loinc.org | MNS29 [Presence] in Serum or Plasma |
| 101138-6 |
http://loinc.org | ER^a Ab [Presence] in Serum or Plasma |
| 10113-9 |
http://loinc.org | ST wave end displacement in lead V2 |
| 101139-4 |
http://loinc.org | Hro Ab [Presence] in Serum or Plasma |
| 101140-2 |
http://loinc.org | Salmonella sp Ag [Presence] in Stool by Rapid immunoassay |
| 101142-8 |
http://loinc.org | NAT2 gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal |
| 101143-6 |
http://loinc.org | NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
| 101144-4 |
http://loinc.org | Ustekinumab and Ustekinumab Ab panel - Serum or Plasma |
| 101145-1 |
http://loinc.org | Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay --trough |
| 101146-9 |
http://loinc.org | Monocyte subsets panel - Blood by Flow cytometry (FC) |
| 10114-7 |
http://loinc.org | ST wave end displacement in lead V3 |
| 101147-7 |
http://loinc.org | Monocytes/100 leukocytes in Blood by Flow cytometry (FC) |
| 101148-5 |
http://loinc.org | CD14+CD16- (Classical) Monocytes/100 Monocytes in Blood |
| 101149-3 |
http://loinc.org | Borrelia burgdorferi IgM Ab index [Units/volume] in Serum and CSF |
| 101150-1 |
http://loinc.org | Right ventricular Cardiac output by Fick method |
| 101151-9 |
http://loinc.org | Right ventricular Cardiac output by Indicator dilution |
| 101153-5 |
http://loinc.org | Chemokine (C-C motif) ligand 14 [Mass/volume] in Urine by Immunoassay |
| 10115-4 |
http://loinc.org | ST wave end displacement in lead V4 |
| 101154-3 |
http://loinc.org | Calprotectin [Mass/volume] in Serum or Plasma |
| 101155-0 |
http://loinc.org | Alpha hydroxyetizolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101156-8 |
http://loinc.org | Alpha hydroxyetizolam [Presence] in Urine by Confirmatory method |
| 101157-6 |
http://loinc.org | Flualprazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101158-4 |
http://loinc.org | Flualprazolam [Presence] in Urine by Confirmatory method |
| 101159-2 |
http://loinc.org | Flubromazolam/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 1011-6 |
http://loinc.org | E sup(w) Ab [Presence] in Serum or Plasma from Donor |
| 101160-0 |
http://loinc.org | Flubromazolam [Presence] in Urine by Confirmatory method |
| 101161-8 |
http://loinc.org | p-Fluorofentanyl/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 10116-2 |
http://loinc.org | ST wave end displacement in lead V5 |
| 101162-6 |
http://loinc.org | p-Fluorofentanyl [Presence] in Urine by Confirmatory method |
| 101163-4 |
http://loinc.org | Brorphine [Mass/volume] in Urine by Confirmatory method |
| 101164-2 |
http://loinc.org | Brorphine/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101165-9 |
http://loinc.org | Brorphine [Presence] in Urine by Confirmatory method |
| 101166-7 |
http://loinc.org | Metonitazene [Mass/volume] in Urine by Confirmatory method |
| 101167-5 |
http://loinc.org | Metonitazene/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101168-3 |
http://loinc.org | Metonitazene [Presence] in Urine by Confirmatory method |
| 101169-1 |
http://loinc.org | 2-methyl AP-237 [Mass/volume] in Urine by Confirmatory method |
| 10117-0 |
http://loinc.org | ST wave end displacement in lead V6 |
| 101170-9 |
http://loinc.org | Soluble urokinase plasminogen activator receptor [Mass/volume] in Serum or Plasma |
| 101171-7 |
http://loinc.org | 2-methyl AP-237/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101172-5 |
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen by NAA with probe detection |
| 101173-3 |
http://loinc.org | Melatonin [Moles/volume] in Saliva (oral fluid) |
| 101174-1 |
http://loinc.org | 17-Hydroxyprogesterone [Mass/volume] in Saliva (oral fluid) |
| 101175-8 |
http://loinc.org | 3-Methoxytyramine.free/Creatinine [Molar ratio] in Serum or Plasma |
| 101176-6 |
http://loinc.org | Normetanephrine Free/Creatinine [Molar ratio] in Serum or Plasma |
| 101177-4 |
http://loinc.org | Metanephrine Free/Creatinine [Molar ratio] in Serum or Plasma |
| 101178-2 |
http://loinc.org | Pneumocystis jiroveci DNA [Cycle Threshold #] in Respiratory system specimen by NAA with probe detection |
| 101179-0 |
http://loinc.org | Immunoglobulin light chains.free/Protein.total in 24 hour Urine |
| 101180-8 |
http://loinc.org | 2-methyl AP-237 [Presence] in Urine by Confirmatory method |
| 101181-6 |
http://loinc.org | MDMB-4en-PINACA [Mass/volume] in Urine by Confirmatory method |
| 101182-4 |
http://loinc.org | MDMB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101183-2 |
http://loinc.org | MDMB-4en-PINACA [Presence] in Urine by Confirmatory method |
| 101184-0 |
http://loinc.org | 4F-MDMB-BINACA [Mass/volume] in Urine by Confirmatory method |
| 101185-7 |
http://loinc.org | 4F-MDMB-BINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101186-5 |
http://loinc.org | 4F-MDMB-BINACA [Presence] in Urine by Confirmatory method |
| 101187-3 |
http://loinc.org | ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method |
| 10118-8 |
http://loinc.org | ST wave mid displacement in lead AVF |
| 101188-1 |
http://loinc.org | ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101189-9 |
http://loinc.org | ADB-BUTINACA [Presence] in Urine by Confirmatory method |
| 101190-7 |
http://loinc.org | 5F-MDMB-PICA [Mass/volume] in Urine by Confirmatory method |
| 101191-5 |
http://loinc.org | 5F-MDMB-PICA/Creatinine [Mass Ratio] in Urine by Confirmatory method |
| 101192-3 |
http://loinc.org | 5F-MDMB-PICA [Presence] in Urine by Confirmatory method |
| 101193-1 |
http://loinc.org | Sphincter excision plane [Anatomy] in Colorectal cancer specimen |
| 101194-9 |
http://loinc.org | Mesocolic excision plane [Anatomy] in Colorectal cancer specimen |
| 101195-6 |
http://loinc.org | Depth of invasion beyond muscularis propria [Length] in Colorectal cancer specimen |
| 10119-6 |
http://loinc.org | ST wave mid displacement in lead AVL |
| 101196-4 |
http://loinc.org | Inflammatory cell infiltrate in Colorectal cancer specimen |
| 101197-2 |
http://loinc.org | Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen |
| 101198-0 |
http://loinc.org | Albumin [Mass/volume] in Serum or Plasma by Nephelometry |
| 101199-8 |
http://loinc.org | Protein.monoclonal band 5/Protein.total in Serum or Plasma by Electrophoresis |
| 101200-4 |
http://loinc.org | Protein.monoclonal band 6/Protein.total in Serum or Plasma by Electrophoresis |
| 101201-2 |
http://loinc.org | Measles virus IgG Ab index [Units/volume] in Serum and CSF |
| 101202-0 |
http://loinc.org | Mumps virus IgG Ab index [Units/volume] in Serum and CSF |
Additional Language Displays
| Code | Deutsch (Österreich) (German (Austria), de) | Deutsch (Deutschland) (German (Germany), de) | English (United States) (English (United States), en) | Spanish (Argentina) (es) | Spanish (es) | Nederlands (Nederland) (Dutch (Netherlands), nl) | Portuguese (Brazil) (pt) |
| 100000-9 | Health Info Pioneer+Father of LOINC | ||||||
| 100001-7 | Health Info Pioneer+Cofound LOINC | ||||||
| 100002-5 | Specimen care is maintained | ||||||
| 100003-3 | Team communication is maintained throughout care | ||||||
| 100004-1 | Demonstrates knowledge of the expected psychosocial responses to the procedure | ||||||
| 100005-8 | Demonstrates knowledge of nutritional management related to the procedure | ||||||
| 100006-6 | Demonstrates knowledge of medication management | ||||||
| 100007-4 | Demonstrates knowledge of pain management | ||||||
| 10000-8 | R wave dur L-AVR | duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-AVR | |||
| 100008-2 | Demonstrates knowledge of wound management | ||||||
| 100009-0 | Demonstrates knowledge of the procedure and expected results | ||||||
| 100010-8 | No injury related to procedure equipment, medical supplies, or instrumentation | ||||||
| 100011-6 | No injury related to an electrical source | ||||||
| 100012-4 | Participates in decisions affecting the patient's plan of care | ||||||
| 100013-2 | Participates in the discharge process | ||||||
| 100014-0 | Psychosocial health is maintained at or improved from baseline | ||||||
| 100015-7 | No injury related to positioning due to care or procedure | ||||||
| 10001-6 | R wave dur L-I | duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-I | |||
| 100016-5 | No injury related to a laser source | ||||||
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] | ||||||
| 100019-9 | ALK gene targeted mutation analysis, Blood or tissue specimen | ALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100020-7 | GNA11 gene targeted mutation analysis, Blood or tissue specimen | GNA11-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100021-5 | GNAQ gene targeted mutation analysis, Blood or tissue specimen | GNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100022-3 | IDH1 gene targeted mutation analysis, Blood or tissue specimen | IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100023-1 | IDH2 gene targeted mutation analysis, Blood or tissue specimen | IDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 10002-4 | R wave dur L-II | duración de la onda R.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-II | |||
| 100024-9 | SETBP1 gene targeted mutation analysis, Blood or tissue specimen | SETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100025-6 | SRSF2 gene targeted mutation analysis, Blood or tissue specimen | SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100026-4 | MET gene targeted mutation analysis, Blood or tissue specimen | MET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100027-2 | SMAD4 gene targeted mutation analysis, Blood or tissue specimen | SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100028-0 | FBXW7 gene targeted mutation analysis, Blood or tissue specimen | FBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100030-6 | Axis I: Temporal aspects score [Mainz Pain Staging System] | ||||||
| 100031-4 | Axis II: Spatial aspects score [Mainz Pain Staging System] | ||||||
| 10003-2 | R wave dur L-III | duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-III | |||
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | ||||||
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | ||||||
| 100034-8 | Provider of AED | ||||||
| 100035-5 | Exam finding location Chest | ||||||
| 100036-3 | Exam finding location Lung | ||||||
| 100037-1 | Patient contact disposition EMS unit | ||||||
| 100038-9 | Patient eval disposition EMS unit | ||||||
| 100039-7 | Crew disposition EMS unit | ||||||
| 10004-0 | R wave dur L-V1 | duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V1 | |||
| 100040-5 | Pt transport disposition EMS unit | ||||||
| 100041-3 | Aminoglycosid-Empfindlichkeit | Aminoglycosid [Empfindlichkeit] | Susceptibility to Aminoglycoside | ||||
| 100042-1 | Atovaquon-Empfindlichkeit | Susceptibility to Atovaquone | Atovaquone [gevoeligheid] in isolaat | ||||
| 100043-9 | Azithromycin/Ethambutol-Empfindlichkeit | Azithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Azithromycin+Ethambutol | Azitromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100044-7 | Cefcapene-Empfindlichkeit | Cefcapen [Empfindlichkeit] | Susceptibility to Cefcapene | Cefcapeen [gevoeligheid] in isolaat | |||
| 100045-4 | Cefozopran-Empfindlichkeit | Susceptibility to Cefozopran | Cefozopran [gevoeligheid] in isolaat | ||||
| 100046-2 | Cefquinom-Empfindlichkeit | Susceptibility to Cefquinome | Cefquinome [gevoeligheid] in isolaat | ||||
| 100047-0 | Cefteram-Empfindlichkeit | Susceptibility to Cefteram | Cefteram [gevoeligheid] in isolaat | ||||
| 100048-8 | Clarithromycin/Ethambutol-Empfindlichkeit | Clarithromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Clarithromycin+Ethambutol | Clarithromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100049-6 | Eravacycline-Empfindlichkeit | Eravacyclin [Empfindlichkeit] | Susceptibility to Eravacycline | Eravacycline [gevoeligheid] in isolaat | |||
| 100050-4 | Erythromycin/Ethambutol-Empfindlichkeit | Erythromycin+Ethambutol [Empfindlichkeit] | Susceptibility to Erythromycin+Ethambutol | Erytromycine + ethambutol [gevoeligheid] in isolaat | |||
| 100051-2 | Ethambutol/rifAMPin-Empfindlichkeit | Ethambutol+Rifampicin [Empfindlichkeit] | Susceptibility to Ethambutol+rifAMPin | Ethambutol + rifampicine [gevoeligheid] in isolaat | |||
| 100052-0 | Flomoxef-Empfindlichkeit | Flomoxef [Empfindlichkeit] | Susceptibility to Flomoxef | Flomoxef [gevoeligheid] in isolaat | |||
| 100053-8 | Fluoroquinolon-Empfindlichkeit | Fluorchinolon [Empfindlichkeit] | Susceptibility to Fluoroquinolone | Fluorchinolon [gevoeligheid] in isolaat | |||
| 100054-6 | Gamithromycin-Empfindlichkeit | Susceptibility to Gamithromycin | |||||
| 100055-3 | Optochin-Empfindlichkeit | Optochin [Empfindlichkeit] | Susceptibility to Optochin | Optochine [gevoeligheid] in isolaat | |||
| 100056-1 | Panipenem-Empfindlichkeit | Panipenem [Empfindlichkeit] | Susceptibility to Panipenem | Panipenem [gevoeligheid] in isolaat | |||
| 10005-7 | R wave dur L-V2 | duración de la onda R.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V2 | |||
| 100057-9 | Prothionamid-Empfindlichkeit | Prothionamid [Empfindlichkeit] | Susceptibility to Prothionamide | Prothionamide [gevoeligheid] in isolaat | |||
| 100058-7 | Prulifloxacin-Empfindlichkeit | Prulifloxacin [Empfindlichkeit] | Susceptibility to Prulifloxacin | Prulifloxacine [gevoeligheid] in isolaat | |||
| 100059-5 | Rifapentin-Empfindlichkeit | Rifapentin [Empfindlichkeit] | Susceptibility to Rifapentine | Rifapentine [gevoeligheid] in isolaat | |||
| 100060-3 | Tildipirosin-Empfindlichkeit | Susceptibility to Tildipirosin | |||||
| 100061-1 | Tosufloxacin-Empfindlichkeit | Tosufloxacin [Empfindlichkeit] | Susceptibility to Tosufloxacin | Tosufloxacine [gevoeligheid] in isolaat | |||
| 100062-9 | SDOM panel | ||||||
| 100063-7 | Primary skin concern | ||||||
| 100064-5 | Itch severity RptPeriod Reported | ||||||
| 10006-5 | R wave dur L-V3 | duración de la onda R.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V3 | |||
| 100065-2 | Satisfied with treatment | ||||||
| 100066-0 | Specular microscopy panel | Endotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie | |||||
| 100067-8 | Eye Image magnification | ||||||
| 100068-6 | R eye Fixation point [Angle] | ||||||
| 100069-4 | L eye Fixation point [Angle] | ||||||
| 100070-2 | R cornea Cell density | ||||||
| 100071-0 | L cornea Cell density | ||||||
| 100072-8 | R cornea Coefficient of variation | ||||||
| 10007-3 | R wave dur L-V4 | duración de la onda R.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V4 | |||
| 100073-6 | L cornea Coefficient of variation | ||||||
| 100074-4 | R cornea Hexagonality | ||||||
| 100075-1 | L cornea Hexagonality | ||||||
| 100076-9 | R cornea Endothelial cells counted | ||||||
| 100077-7 | L cornea Endothelial cells counted | ||||||
| 100078-5 | R cornea Endothelial cell area.min | ||||||
| 100079-3 | L cornea Endothelial cell area.min | ||||||
| 100080-1 | R cornea Endothelial cell area.max | ||||||
| 10008-1 | R wave dur L-V5 | duración de la onda R.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V5 | |||
| 100081-9 | L cornea Endothelial cell area.max | ||||||
| 100082-7 | R cornea Endothelial cell area.mean | ||||||
| 100083-5 | L cornea Endothelial cell area.mean | ||||||
| 100084-3 | R cornea Cell area.sd | ||||||
| 100085-0 | L cornea Cell area.sd | ||||||
| 100086-8 | R cornea Analysis method | ||||||
| 100087-6 | Toxocara canis 24-35kD IgG antibody, Blood | Toxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100088-4 | Taenia solium larva Ab bands panel, Blood | Taenia solium larve As banden panel in serum d.m.v. immunoblotting | |||||
| 100089-2 | Taenia solium larva 6-8kD antibody, Blood | Taenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 1000-9 | DBG antibody, Blood Product Unit | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: | DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^bloedproducteenheid | DBG Ac SerPl BPU Ql | ||
| 100090-0 | Taenia solium larva 45kD antibody, Blood | Taenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100091-8 | Trypanosoma cruzi antibody, Blood | Trypanosoma cruzi As [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100092-6 | Trypanosoma cruzi Ab bands panel, Blood | Trypanosoma cruzi As banden panel in serum d.m.v. immunoblotting | |||||
| 100093-4 | Trypanosoma cruzi 15-16kD IgG antibody, Blood | Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100094-2 | Trypanosoma cruzi 21-22kD IgG antibody, Blood | Trypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100095-9 | Trypanosoma cruzi 27-28kD IgG antibody, Blood | Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100096-7 | Trypanosoma cruzi 42kD IgG antibody, Blood | Trypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100097-5 | Trypanosoma cruzi 45-47kD IgG antibody, Blood | Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100098-3 | Trypanosoma cruzi 120-200kD IgG antibody, Blood | Trypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10009-9 | R wave dur L-V6 | duración de la onda R.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V6 | |||
| 100099-1 | Trypanosoma cruzi 160kD IgG antibody, Blood | Trypanosoma cruzi 160kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100100-7 | Fasciola sp IgG antibody, Blood | Fasciola sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100101-5 | Fasciola sp 8-9kD IgG antibody, Blood | Fasciola sp. 8-9kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100102-3 | Fasciola sp 27-28kD IgG antibody, Blood | Fasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100103-1 | Fasciola sp 60kD IgG antibody, Blood | Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100104-9 | Fasciola sp 42kD IgG antibody, Blood | Fasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100105-6 | Filaria IgG and IgM panel, Blood | Filaria As.IgG & IgM panel in serum | |||||
| 100106-4 | Filaria IgG antibody, Blood | Filaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 10010-7 | R' wave Amp L-AVF | amplitud de la onda R'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVF | |||
| 100107-2 | Leishmania sp IgG antibody, Blood | Leishmania sp. As.IgG [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100108-0 | Leishmania sp IgG antibody, Blood | Leishmania sp. As.IgG [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100109-8 | Leishmania sp Ab bands panel, Blood | Leishmania sp. As banden panel in serum d.m.v. immunoblotting | |||||
| 100110-6 | Leishmania sp 14kD IgG antibody, Blood | Leishmania sp. 14kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100111-4 | Leishmania sp 16kD IgG antibody, Blood | Leishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100112-2 | Fasciola sp Ab bands panel, Blood | Fasciola sp. As-banden panel in serum d.m.v. immunoblotting | |||||
| 100113-0 | Helicobacter pylori Ab panel, Blood | Helicobacter pylori As panel in serum | |||||
| 100114-8 | Toxoplasma gondii 30kD antibody, Blood | Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10011-5 | R' wave Amp L-AVL | amplitud de la onda R'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVL | |||
| 100115-5 | Toxoplasma gondii 31kD antibody, Blood | Toxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100116-3 | Toxoplasma gondii 33kD antibody, Blood | Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100117-1 | Toxoplasma gondii 40kD antibody, Blood | Toxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100118-9 | Toxoplasma gondii 41kD antibody, Blood | Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100119-7 | Toxoplasma gondii 45kD antibody, Blood | Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100120-5 | Chlamydia trachomatis Ab panel, Blood | Chlamydia trachomatis As panel in serum | |||||
| 100121-3 | Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels Immunoassay | Chlamydia trachomatis IgA antibody, Blood | Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay | ||||
| 100122-1 | C. pneumoniae Ab panel, Blood | Chlamydophila pneumoniae As panel in serum | |||||
| 10012-3 | R' wave Amp L-AVR | amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVR | |||
| 100123-9 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydophila pneumoniae As.IgA [aanwezigheid] in serum d.m.v. immunoassay | |||||
| 100124-7 | Chlamydophila pneumoniae IgA antibody, Blood | Chlamydophila pneumoniae As.IgA [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100125-4 | C. psittaci Ab panel, Blood | Chlamydophila psittaci As panel in serum | |||||
| 100126-2 | Bordetella pertussis Ab.IgG panel, Blood | Bordetella pertussis As.IgG panel in serum | |||||
| 100127-0 | Campylobacter sp Ab panel, Blood | Campylobacter sp. As panel in serum | |||||
| 100128-8 | Cryptococcus sp Ag panel, Blood | Cryptococcus sp. Ag panel in serum | |||||
| 100129-6 | Schistosoma sp antibody, Blood | Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie | |||||
| 100130-4 | Schistosoma mansoni antibody, Blood | Schistosoma mansoni As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 10013-1 | R' wave Amp L-I | amplitud de la onda R'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda R '. I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-I | |||
| 100131-2 | Schistosoma sp 8kD antibody, Blood | Schistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100132-0 | Schistosoma sp 9kD antibody, Blood | Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100133-8 | Schistosoma sp 10kD antibody, Blood | Schistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100134-6 | Schistosoma sp 11kD antibody, Blood | Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100135-3 | Schistosoma sp 12-13kD antibody, Blood | Schistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100136-1 | Schistosoma sp 14-15kD antibody, Blood | Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100137-9 | Schistosoma sp 15-16kD antibody, Blood | Schistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100138-7 | Schistosoma sp 18-19kD antibody, Blood | Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100139-5 | Schistosoma sp 22-24kD antibody, Blood | Schistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100140-3 | Schistosoma sp 30-34kD antibody, Blood | Schistosoma sp. 30-34kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100141-1 | Schistosoma sp 65kD antibody, Blood | Schistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100142-9 | Schistosoma sp 70kD antibody, Blood | Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100143-7 | Schistosoma sp 80kD antibody, Blood | Schistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100144-5 | Schistosoma sp 95kD antibody, Blood | Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100145-2 | Schistosoma sp 110kD antibody, Blood | Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100146-0 | Schistosoma sp 120kD antibody, Blood | Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100147-8 | Toxoplasma gondii Ab bands panel, Blood | Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting | |||||
| 100148-6 | Schistosoma sp Ab bands panel, Blood | Schistosoma sp. As banden panel in serum d.m.v. immunoblotting | |||||
| 10014-9 | R' wave Amp L-II | amplitud de la onda R'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-II | |||
| 100149-4 | 6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel, Urine+Blood | 6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma | |||||
| 100150-2 | 6(R+S)-oxo-propylpiperidine-2-carboxylate, Blood | 6(R+S)-oxo-propylpiperidine-2-carboxylaat [mol/volume] in plasma | |||||
| 100151-0 | 6-oxo-piperidine-2-carboxylate, Blood | 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma | |||||
| 100152-8 | 6-oxo-piperidine-2-carboxylate/Creatinine, Urine | 6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
| 100153-6 | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine | 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
| 100154-4 | Collection supervision level, Specimen | ||||||
| 100155-1 | L cornea Analysis method | ||||||
| 10015-6 | R' wave Amp L-III | amplitud de la onda R'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-III | |||
| 100156-9 | SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | SARS-CoV-2 (COVID-19) variant, Specimen | SARS-CoV-2-variant [type] d.m.v. probe-detectie | ||||
| 100157-7 | SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung | SARS-CoV-2 (COVID-19) lineage, Specimen | SARS-CoV-2 lineage [type] d.m.v. sequencing | ||||
| 100158-5 | Albumin, Urine | Albumine [massa/volume] in urine (verzamelduur niet gespecificeerd) d.m.v. detectielimiet <= 20 mg/L | |||||
| 100159-3 | Knee Society Score pre-op panel [Knee Society Score] | ||||||
| 100160-1 | Knee replacement | ||||||
| 100161-9 | Charnley Functional Classification | ||||||
| 100162-7 | Alignment W Stand Knee XR | ||||||
| 100163-5 | Knee medial AndOr lateral instability W full extension | ||||||
| 10016-4 | R' wave Amp L-V1 | amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V1 | |||
| 100164-3 | Knee AP instability W 90 degree flexion | ||||||
| 100165-0 | Knee Qn | ||||||
| 100166-8 | Flexion contracture range Knee | ||||||
| 100167-6 | Extensor lag range Knee | ||||||
| 100168-4 | Knee pain severity with level walking | ||||||
| 100169-2 | Knee pain severity with stairs or inclines | ||||||
| 1001-7 | DBG antibody, Donor Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: | DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma^donor | DBG Ac SerPl Donr Ql | ||
| 100170-0 | Knee feels normal | ||||||
| 100171-8 | Satisfaction with level of knee pain while sitting | ||||||
| 10017-2 | R' wave Amp L-V2 | amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V2 | |||
| 100172-6 | Satisfaction with level of knee pain while lying in bed | ||||||
| 100173-4 | Satisfaction with knee function while getting out of bed | ||||||
| 100174-2 | Satisfaction with knee function while performing light household duties | ||||||
| 100175-9 | Satisfaction with knee function while performing recreational activities | ||||||
| 100176-7 | Expect surgery to relieve pain | ||||||
| 100177-5 | Expect surgery will improve ability to perform activities of daily living | ||||||
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | ||||||
| 100179-1 | Walk without assistive mobility devices | ||||||
| 10018-0 | R' wave Amp L-V3 | amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V3 | |||
| 100180-9 | Assistive mobility devices used | ||||||
| 100181-7 | Assistive mobility devices used due to health condition | ||||||
| 100182-5 | Duration of standing before sitting due to knee discomfort | ||||||
| 100183-3 | Duration of walking before stopping due to knee discomfort | ||||||
| 100184-1 | How bothersome is knee when walking on an uneven surface | ||||||
| 100185-8 | How bothersome is knee when turning or pivoting leg | ||||||
| 100186-6 | How bothersome is knee when climbing up or down a flight of stairs | ||||||
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests | ||||||
| 100188-2 | How bothersome is knee when getting into or out of a car | ||||||
| 100189-0 | How bothersome is knee when moving laterally | ||||||
| 100190-8 | How bothersome is knee when climbing a ladder or step stool | ||||||
| 100191-6 | How bothersome is knee when carrying a bag for one block | ||||||
| 100192-4 | How bothersome is knee when squatting | ||||||
| 100193-2 | How bothersome is knee when kneeling | ||||||
| 100194-0 | How bothersome is knee when running | ||||||
| 100195-7 | Pain severity--during activity | ||||||
| 100196-5 | Pre-op total score [Knee Society Score] | ||||||
| 100197-3 | Exercise activity and pain severity panel | ||||||
| 10019-8 | R' wave Amp L-V4 | amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V4 | |||
| 100198-1 | Pre-op objective knee indicators score [Knee Society Score] | ||||||
| 100199-9 | Pre-op symptoms score [Knee Society Score] | ||||||
| 100200-5 | Pre-op patient expectations score [Knee Society Score] | ||||||
| 100201-3 | Pre-op functional activities score [Knee Society Score] | ||||||
| 100202-1 | Pre-op discretionary knee activities score [Knee Society Score] | ||||||
| 100203-9 | Knee Society Score post-op panel [Knee Society Score] | ||||||
| 100204-7 | Accuracy of pre-surgery expectations of pain relief | ||||||
| 100205-4 | Accuracy of pre-surgery expectations to perform activities of daily living | ||||||
| 10020-6 | R' wave Amp L-V5 | amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V5 | |||
| 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | ||||||
| 100207-0 | Post-op total score [Knee Society Score] | ||||||
| 100208-8 | Post-op objective knee indicators score [Knee Society Score] | ||||||
| 100209-6 | Post-op symptoms score [Knee Society Score] | ||||||
| 100210-4 | Post-op patient expectations score [Knee Society Score] | ||||||
| 100211-2 | Post-op functional activities score [Knee Society Score] | ||||||
| 100212-0 | Post-op discretionary knee activities score [Knee Society Score] | ||||||
| 10021-4 | R' wave Amp L-V6 | amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V6 | |||
| 100216-1 | Surgical synoptic report | Beknopt rapport [bevinding] d.m.v. chirurgie (tekstueel) | |||||
| 100217-9 | Synoptic report Surg Onc | ||||||
| 100218-7 | Surg onc colon CA synoptic rep | ||||||
| 100219-5 | Surg onc melanoma CA synoptic rep | ||||||
| 100220-3 | Surg onc breast CA synoptic rep | ||||||
| 100221-1 | Surg onc thyroid CA synoptic rep | ||||||
| 10022-2 | R' wave dur L-AVF | duración de la onda R'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVF | |||
| 100222-9 | Surg onc pancreas CA synoptic rep | ||||||
| 100223-7 | Retina Phys find | ||||||
| 100224-5 | Cardiac LV SWM Pnl LV US | ||||||
| 10023-0 | R' wave dur L-AVL | duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVL | |||
| 100230-2 | Routine prenatal pnl | ||||||
| 100232-8 | Impacts of Events Scale-Revised panel | ||||||
| 100233-6 | Reminders brought back feelings about adverse event | ||||||
| 100234-4 | Trouble staying asleep | ||||||
| 100235-1 | Other things triggered persistent thoughts about adverse event | ||||||
| 100236-9 | Felt irritable AndOr angry | ||||||
| 100237-7 | Avoided getting upset when unintentionally thought about adverse event | ||||||
| 100238-5 | Thought about adverse event unintentionally | ||||||
| 100239-3 | Felt as if adverse event did not happen | ||||||
| 100240-1 | Avoided reminders of adverse event | ||||||
| 100241-9 | Experienced mental images of adverse event | ||||||
| 100242-7 | Easily startled | ||||||
| 100243-5 | Tried to not think of adverse event | ||||||
| 100244-3 | Aware of feelings about adverse event, but did not address them | ||||||
| 100245-0 | Feelings about adverse event were numb | ||||||
| 100246-8 | Acted or felt the same as during adverse event | ||||||
| 100247-6 | Trouble falling asleep | ||||||
| 10024-8 | R' wave dur L-AVR | duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVR | |||
| 100248-4 | Waves of strong feelings about adverse event | ||||||
| 100249-2 | Tried to remove adverse event from memory | ||||||
| 1002-5 | DBG antibody, Blood | [anticuerpo anti - ] DBG [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | DBG As [aanwezigheid] in serum of plasma | DBG Ac SerPl Ql | ||
| 100250-0 | Trouble concentrating | ||||||
| 100251-8 | Reminders of adverse event caused physical reactions | ||||||
| 100252-6 | Had dreams about adverse event | ||||||
| 100253-4 | Felt watchful and on-guard | ||||||
| 100254-2 | Tried not to talk about adverse event | ||||||
| 10025-5 | R' wave dur L-I | duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-I | |||
| 100255-9 | Total score [Impact of Event Scale-Revised] | ||||||
| 100256-7 | Fallen in last 6Mo | ||||||
| 100257-5 | Feel unsteady when standing or walking | ||||||
| 100258-3 | History of fall related injury | ||||||
| 100259-1 | Aware of tactile sensations | ||||||
| 100260-9 | Easy to describe thoughts AndOr feelings | ||||||
| 100261-7 | Critical of own thoughts AndOr feelings | ||||||
| 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | ||||||
| 10026-3 | R' wave dur L-II | duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-II | |||
| 100263-3 | Easily distracted | ||||||
| 100264-1 | Able to notice thoughts AndOr feelings without being overwhelmed | ||||||
| 100265-8 | Aware of dietary intake impact on self | ||||||
| 100266-6 | Difficult to describe thoughts AndOr feelings | ||||||
| 100267-4 | Aware of auditory stimuli | ||||||
| 100268-2 | Able to avoid immediate reaction in difficult situations | ||||||
| 100269-0 | Do things without paying attention | ||||||
| 100270-8 | Recover quickly from distressing thoughts AndOr images | ||||||
| 10027-1 | R' wave dur L-III | duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-III | |||
| 100271-6 | Aware of olfactory stimuli | ||||||
| 100272-4 | Aware of visual stimuli | ||||||
| 100273-2 | Aware of emotions affect on thoughts AndOr behavior | ||||||
| 100274-0 | Observing score [FFMQ] | ||||||
| 100275-7 | Describing score [FFMQ] | ||||||
| 100276-5 | Acting with awareness score [FFMQ] | ||||||
| 100277-3 | Nonjudging score [FFMQ] | ||||||
| 100278-1 | Nonreactivity score [FFMQ] | ||||||
| 100279-9 | Total score [FFMQ] | ||||||
| 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | ||||||
| 100281-5 | D antibody, Blood | D As [eenheid/volume] in serum of plasma | |||||
| 100283-1 | Harris Hip Score panel [Harris Hip Score] | ||||||
| 100284-9 | Walking - functional ability | ||||||
| 100285-6 | Comfortable seated position | ||||||
| 100286-4 | Able to board public transportation | ||||||
| 100287-2 | Put on shoes and socks | ||||||
| 100288-0 | Absence of deformity score [Harris Hip Score] | ||||||
| 10028-9 | R' wave dur L-V1 | duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V1 | |||
| 100289-8 | Absence of hip deformity measurements | ||||||
| 100290-6 | Range of motion score [Harris Hip Score] | ||||||
| 100291-4 | Total score [Harris Hip Score] | ||||||
| 100292-2 | Pre-op patient satisfaction score [Knee Society Score] | ||||||
| 100293-0 | Hip Flexion range of motion | ||||||
| 100294-8 | Hip Abduction range of motion | ||||||
| 100295-5 | Hip Adduction range of motion | ||||||
| 100296-3 | Hip External rotation range of motion | ||||||
| 10029-7 | R' wave dur L-V2 | duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V2 | |||
| 100297-1 | Hip Internal rotation range of motion | ||||||
| 100298-9 | Rep count | ||||||
| 100299-7 | Post-op patient satisfaction score [Knee Society Score] | ||||||
| 100300-3 | End time | ||||||
| 100301-1 | Start time | ||||||
| 100302-9 | Time start/end panel Spec | ||||||
| 100303-7 | Condition certainty of presence | ||||||
| 100304-5 | Flights climbed RptPeriod | ||||||
| 10030-5 | R' wave dur L-V3 | duración de la onda R'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V3 | |||
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
| 100306-0 | IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | |||||
| 100307-8 | Behavioral screening elder mistreatment | ||||||
| 100308-6 | Need help getting to essential places | ||||||
| 100309-4 | Activity support person | ||||||
| 100310-2 | Reliability of support person | ||||||
| 100311-0 | Need help to make sure there is enough food, medicines or any other things needed in house | ||||||
| 100312-8 | Person or persons that makes sure there is enough food, medicines or any other things needed in house | ||||||
| 10031-3 | R' wave dur L-V4 | duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V4 | |||
| 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | ||||||
| 100314-4 | Need help with house cleaning or yard work | ||||||
| 100315-1 | Need help getting out of bed, showered, or dressed | ||||||
| 100316-9 | Need help to make sure bills get paid | ||||||
| 100317-7 | Relationship of usual support person for daily activities | ||||||
| 100318-5 | Have help with finances AndOr financial decisions | ||||||
| 100319-3 | Relationship of financial support person | ||||||
| 100320-1 | Financial support person usually asks for permission before making decisions | ||||||
| 10032-1 | R' wave dur L-V5 | duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V5 | |||
| 100321-9 | Financial support person usually makes good decisions about finances | ||||||
| 100322-7 | Have access to paperwork for financial decisions made | ||||||
| 100323-5 | Financial support person forged signature | ||||||
| 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | ||||||
| 100325-0 | Experienced theft by support person | ||||||
| 100326-8 | Money spent or property sold without permission | ||||||
| 100327-6 | Stranger forged signature for financial gain | ||||||
| 100328-4 | Stranger forced document signature for financial gain | ||||||
| 100329-2 | Feared for safety due to verbal attack | ||||||
| 1003-3 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico del complemento: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.complement-specifiek reagent [aanwezigheid] in serum of plasma | IAT Comp-Sp Reag SerPl Ql | ||
| 100330-0 | Felt humiliated due to ridicule | ||||||
| 100331-8 | Coerced to do something | ||||||
| 100332-6 | Ignored by close friend or relative for extended period | ||||||
| 100333-4 | Physically hit or threatened | ||||||
| 100334-2 | Been physically hurt with some degree of injury | ||||||
| 100335-9 | Coerced sexual activity | ||||||
| 100336-7 | Coerced touching of private body parts of self or others | ||||||
| 100337-5 | Coerced to undress or expose private body area | ||||||
| 100338-3 | Photographed in any degree of nudity without consent | ||||||
| 10033-9 | R' wave dur L-V6 | duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V6 | |||
| 100339-1 | Experienced attempted physical restraint | ||||||
| 100340-9 | Range of motion panel Hip | ||||||
| 100341-7 | Rötelnvirus Antikörper-Index | Röteln-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und Liquor | Rubella virus IgG index, Serum+Cerebrospinal fluid | Rubellavirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis | |||
| 100342-5 | Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS | Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas | Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie | ||||
| 100343-3 | Influenza-Virus B RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza B (Flu B), Saliva | Influenzavirus B RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
| 100344-1 | Influenza-Virus A RNA [Nachweis] in Speichel mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza A (Flu A), Saliva | Influenzavirus A RNA [aanwezigheid] in speeksel d.m.v. probe-detectie | ||||
| 100345-8 | Influenza-Virus A und Influenza-Virus B und SARS-CoV-2 (COVID-19) RNA (Liste) - Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Specimen | Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie | ||||
| 100346-6 | Clotting Time FIBTEM | Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood | |||||
| 10034-7 | S wave Amp L-AVF | amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVF | |||
| 100347-4 | Clot Formation Time FIBTEM | Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood | |||||
| 100348-2 | MELDNa score | ||||||
| 100350-8 | Sesamum indicum 1 allergy test | Sesamum indicum 1 As.IgE [eenheid/volume] in serum | |||||
| 100351-6 | Pioglitazone, Blood | Pioglitazon [aanwezigheid] in serum of plasma | |||||
| 100352-4 | Rosiglitazone, Blood | Rosiglitazon [aanwezigheid] in serum of plasma | |||||
| 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | ||||||
| 10035-4 | S wave Amp L-AVL | amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVL | |||
| 100354-0 | Frequency of participating in multi-modal communication without assistance | ||||||
| 100355-7 | Frequency of participating in spoken language expression communication without assistance | ||||||
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie | |||||
| 100357-3 | Naloxone, Umbilical cord tissue | Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
| 100358-1 | Phentermine, Umbilical cord tissue | Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening | |||||
| 100359-9 | Gliadin 33 mer peptide, Stool | Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay | |||||
| 100360-7 | Brief Resilience Scale panel [BRS] | ||||||
| 100361-5 | Quickly recover from bad events | ||||||
| 10036-2 | S wave Amp L-AVR | amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVR | |||
| 100362-3 | Difficulty making it through stressful events | ||||||
| 100363-1 | Easily recover from a stressful event | ||||||
| 100364-9 | Difficulty recovering from bad events | ||||||
| 100365-6 | Easily recover from difficulties | ||||||
| 100366-4 | Lengthy recovery from setbacks | ||||||
| 100367-2 | Total Score BRS | ||||||
| 100368-0 | Amino Acids Urea Cycle Panel, Blood | Aminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS | |||||
| 10037-0 | S wave Amp L-I | amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de la onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-I | |||
| 100370-6 | Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus, Specimen | Orthopoxvirus DNA [identificator] d.m.v. probe-detectie | ||||
| 100371-4 | Titin antibody, Blood | ||||||
| 100372-2 | Abiraterone, Blood | Abirateron [massa/volume] in serum of plasma | |||||
| 100373-0 | Agar- agar IgG antibody | Eucheuma As.IgG [eenheid/volume] in serum | |||||
| 100374-8 | Aloe vera IgG antibody | Aloë vera As.IgG [eenheid/volume] in serum | |||||
| 100375-5 | Anise IgG antibody | Pimpinella anisum As.IgG [eenheid/volume] in serum | |||||
| 100376-3 | Bambusa vulgaris IgG antibody | Bambusa vulgaris As.IgG [eenheid/volume] in serum | |||||
| 100377-1 | Goat cheese IgG antibody | Geitenkaas As.IgG [eenheid/volume] in serum | |||||
| 100378-9 | Sheep cheese IgG antibody | Schapenkaas As.IgG [eenheid/volume] in serum | |||||
| 100379-7 | Leeks IgG antibody | Allium ampeloprasum As.IgG [eenheid/volume] in serum | |||||
| 100380-5 | Red cabbage IgG antibody | Brassica rubra As.IgG [eenheid/volume] in serum | |||||
| 100381-3 | Mentha balsamea Wild IgG antibody | Pepermunt As.IgG [eenheid/volume] in serum | |||||
| 100382-1 | FDA insert REMS addressed risk | ||||||
| 100383-9 | Affenpockenvirus-DNA ql. /Sondermaterial PCR | Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus, Specimen | Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||
| 100384-7 | Rapeseed IgG antibody | Brassica rapa As.IgG [eenheid/volume] in serum | |||||
| 100385-4 | Corn salad IgG antibody | Valerianella locusta As.IgG [eenheid/volume] in serum | |||||
| 100386-2 | Rosemary IgG antibody | Rosmarinus officinalis As.IgG [eenheid/volume] in serum | |||||
| 100387-0 | Poppy seed IgG antibody | Papaver somniferum As.IgG [eenheid/volume] in serum | |||||
| 10038-8 | S wave Amp L-II | amplitud de la onda S.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-II | |||
| 100388-8 | Cocoa IgG antibody | Theobroma cacao As.IgG [eenheid/volume] in serum | |||||
| 100389-6 | Pistachio IgG antibody | Pistacia vera As.IgG [eenheid/volume] in serum | |||||
| 100390-4 | Sunflower seed IgG antibody | Helianthus annuus zaad As.IgG [eenheid/volume] in serum | |||||
| 100391-2 | Dates IgG antibody | Phoenix dactylifera As.IgG [eenheid/volume] in serum | |||||
| 100392-0 | Duck meat IgG antibody | Eendenvlees As.IgG [eenheid/volume] in serum | |||||
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody | Paddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum | |||||
| 100394-6 | Decapod crustaceans IgG antibody | Astacoidea As.IgG [eenheid/volume] in serum | |||||
| 100395-3 | Carob IgG antibody | Ceratonia siliqua As.IgG [eenheid/volume] in serum | |||||
| 10039-6 | S wave Amp L-III | amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-III | |||
| 100396-1 | Brassica napus IgG antibody | Brassica napus As.IgG [eenheid/volume] in serum | |||||
| 100397-9 | Goat Meat IgG antibody | Geitenvlees As.IgG [eenheid/volume] in serum | |||||
| 100398-7 | Goose meat IgG antibody | Ganzenvlees As.IgG [eenheid/volume] in serum | |||||
| 100399-5 | Ostrich meat IgG antibody | Struisvogelvlees As.IgG [eenheid/volume] in serum | |||||
| 100400-1 | Quail meat IgG antibody | Kwartelvlees As.IgG [eenheid/volume] in serum | |||||
| 100401-9 | Rabbit meat IgG antibody | Konijnenvlees As.IgG [eenheid/volume] in serum | |||||
| 100402-7 | Venison meat IgG antibody | Hertenvlees As.IgG [eenheid/volume] in serum | |||||
| 100403-5 | Guineafowl IgG antibody | Parelhoen As.IgG [eenheid/volume] in serum | |||||
| 10040-4 | S wave Amp L-V1 | amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V1 | |||
| 100404-3 | Horse meat IgG antibody | Paardenvlees As.IgG [eenheid/volume] in serum | |||||
| 100405-0 | Kefir IgG antibody | Kefir As.IgG [eenheid/volume] in serum | |||||
| 100406-8 | Butter IgG antibody | Boter As.IgG [eenheid/volume] in serum | |||||
| 100407-6 | Camembert cheese IgG antibody | Camembert As.IgG [eenheid/volume] in serum | |||||
| 100408-4 | Emmental cheese IgG antibody | Emmentaler kaas As.IgG [eenheid/volume] in serum | |||||
| 100409-2 | Processed cheese IgG antibody | Smeltkaas As.IgG [eenheid/volume] in serum | |||||
| 1004-1 | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Test de antiglobulina directo, reactivo específico del complemento: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Directe antiglobulinetest.complement specifiek reagens [aanwezigheid] in erytrocyten | DAT Comp-Sp Reag RBC Ql | ||
| 100410-0 | Curd cheese IgG antibody | Kwark As.IgG [eenheid/volume] in serum | |||||
| 100411-8 | Sugar beet IgG antibody | Bèta-vulgaris As.IgG [eenheid/volume] in serum | |||||
| 10041-2 | S wave Amp L-V2 | amplitud de la onda S.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V2 | |||
| 100412-6 | Chinese cabbage IgG antibody | Chinese kool As.IgG [eenheid/volume] in serum | |||||
| 100413-4 | Fennel fresh IgG antibody | Foeniculum vulgare vers As.IgG [eenheid/volume] in serum | |||||
| 100414-2 | Gourd IgG antibody | Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum | |||||
| 100415-9 | Kale IgG antibody | Brassica oleracea var. Borecole As.IgG [eenheid/volume] in serum | |||||
| 100416-7 | Savoy cabbage IgG antibody | Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum | |||||
| 100417-5 | Vitis sp leaf IgG antibody | Blad van Vitis sp. As.IgG [eenheid/volume] in serum | |||||
| 100418-3 | Liquorice IgG antibody | Glycyrrhiza glabra As.IgG [eenheid/volume] in serum | |||||
| 100419-1 | Snow pea IgG antibody | Pisum sativum var. saccharatum As.IgG [eenheid/volume] in serum | |||||
| 10042-0 | S wave Amp L-V3 | amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V3 | |||
| 100420-9 | Fava bean IgG antibody | Vicia faba As.IgG [eenheid/volume] in serum | |||||
| 100421-7 | Chick pea IgG antibody | Cicer arietinus As.IgG [eenheid/volume] in serum | |||||
| 100422-5 | Chicory IgG antibody | Cichorium intybus As.IgG [eenheid/volume] in serum | |||||
| 100423-3 | Button + oyster + Shiitaki + chanterelle mushroom IgG antibody | Paddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum | |||||
| 100424-1 | 8(9)-Cholestenol, Blood | 8(9)-cholestenol [massa/volume] in serum of plasma | |||||
| 100425-8 | DiHydro T-Mas, Blood | DiHydro T-Mas [massa/volume] in serum of plasma | |||||
| 100426-6 | Squalene, Blood | ||||||
| 100427-4 | Stigmasterol, Blood | Stigmasterol [massa/volume] in serum of plasma | |||||
| 100428-2 | Carnitine free and total and acylcarnitine panel, Urine | Carnitine.vrij & totaal & acylcarnitine panel in urine | |||||
| 100429-0 | LRBA deficiency panel, Blood | LRBA-deficiëntie panel in bloed | |||||
| 100430-8 | Cells.LRBA+ 100 Cells.CD3+CD14-CD45+, Blood | Cellen.LRBA+/100 cellen.CD3+CD14-CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
| 100431-6 | T-cells LRBA MFI, Blood | Cellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
| 100432-4 | Cells.LRBA+ 100 Cells.CD3-CD14-CD19+CD45+, Blood | Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
| 100433-2 | B-cells LRBA MFI, Blood | Cellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | |||||
| 100434-0 | Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus.non-variola, Specimen | Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100435-7 | Glial fibrillary acidic protein, Blood | Gliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay | |||||
| 100436-5 | Ubiquitin carboxyl-terminal hydrolase-L1, Blood | ||||||
| 100437-3 | Norsufentanil, Urine | Norsufentanil [massa/volume] in urine d.m.v. bevestiging | |||||
| 10043-8 | S wave Amp L-V4 | amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V4 | |||
| 10044-6 | S wave Amp L-V5 | amplitud de la onda S.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V5 | |||
| 10045-3 | S wave Amp L-V6 | amplitud de la onda S.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V6 | |||
| 10046-1 | S wave dur L-AVF | duración de la onda S.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVF | |||
| 10047-9 | S wave dur L-AVL | duración de la onda S.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVL | |||
| 10048-7 | S wave dur L-AVR | duración de la onda S.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVR | |||
| 10049-5 | S wave dur L-I | duración de la onda S.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Conduzca I:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-I | |||
| 10050-3 | S wave dur L-II | duración de la onda S.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-II | |||
| 10051-1 | S wave dur L-III | duración de la onda S.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-III | |||
| 10052-9 | S wave dur L-V1 | duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V1 | |||
| 10053-7 | S wave dur L-V2 | duración de la onda S.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V2 | |||
| 10054-5 | S wave dur L-V3 | duración de la onda S.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V3 | |||
| 10055-2 | S wave dur L-V4 | duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V4 | |||
| 10056-0 | S wave dur L-V5 | duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V5 | |||
| 10057-8 | S wave dur L-V6 | duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V6 | |||
| 1005-8 | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta Reactivo específico IgG: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.IgG-specifiek reagent [aanwezigheid] in serum of plasma | IAT IgG-Sp Reag SerPl Ql | ||
| 10058-6 | S' wave Amp L-AVF | amplitud de la onda S'.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVF | |||
| 10059-4 | S' wave Amp L-AVL | amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVL | |||
| 10060-2 | S' wave Amp L-AVR | amplitud de la onda S'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVR | |||
| 10061-0 | S' wave Amp L-I | amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-I | |||
| 10062-8 | S' wave Amp L-II | amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-II | |||
| 10063-6 | S' wave Amp L-III | amplitud de la onda S'.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-III | |||
| 10064-4 | S' wave Amp L-V1 | amplitud de la onda S'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V1 | |||
| 10065-1 | S' wave Amp L-V2 | amplitud de la onda S'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V2 | |||
| 100652-7 | Pure tone bone thresh Pnl | ||||||
| 100653-5 | Pure tone air thresh Pnl | ||||||
| 100654-3 | M2-PK (Pyruvatkinase) /Stuhl | Pyruvate kinase M2, Stool | Pyruvaatkinase M2 [aanwezigheid] in feces | ||||
| 1006-6 | Direkt-Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: | Prueba de antiglobulina directa Reactivo específico IgG: Eritrocitos : Punto temporal: Impresión / interpretación del estudio: Nominal: | Directe antiglobulinetest.IgG specifiek reagens [interpretatie] in erytrocyten | DAT IgG-Sp Reag RBC-Imp | |
| 100662-6 | Cortisol free and total panel, Blood | Cortisol vrij & totaal panel in serum of plasma | |||||
| 100663-4 | TPMT gene c.460G>A&c.719A>G, Blood | TPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100664-2 | NUDT15 gene c.50_55dup&c.415C>T, Blood | NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100665-9 | NUDT15 gene c.415C>T, Blood | NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100666-7 | NUDT15 gene c.52G>A, Blood | NUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100667-5 | NUDT15 gene c.52G>A, Blood | NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100668-3 | NUDT15 gene c.50_55dup, Blood | NUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 10066-9 | S' wave Amp L-V3 | amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V3 | |||
| 100669-1 | NUDT15 gene c.50_55del, Blood | NUDT15-gen c.50_55del [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100670-9 | Fetal RHD gene allele--fetus | RHD-allel^foetus [identificator] in plasma.celvrij DNA | |||||
| 100671-7 | Aspergillus sp, Blood | Aspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100672-5 | Aspergillus fumigatus, Blood | Aspergillus fumigatus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100673-3 | Aspergillus terreus, Blood | Aspergillus terreus DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 100674-1 | BK virus, Blood | BK-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100675-8 | Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomegalovirus DNA [eenheid/volume] in bloed d.m.v. probe-detectie | ||||
| 100676-6 | Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Cytomegalovirus (CMV), Blood | Cytomegalovirus DNA [logaritmische eenheid/volume] in bloed d.m.v. probe-detectie | ||||
| 10067-7 | S' wave Amp L-V4 | amplitud de la onda S'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V4 | |||
| 100677-4 | Epstein Barr virus (EBV), Blood | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100678-2 | Epstein Barr virus (EBV), Blood | Epstein-Barr-virus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100679-0 | Herpes virus (HHV) 6, Blood | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100680-8 | Herpes virus (HHV) 6, Blood | Humaan betaherpesvirus type 6 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100681-6 | Herpes virus (HHV) 7, Blood | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100682-4 | Herpes virus (HHV) 7, Blood | Humaan betaherpesvirus type 7 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100683-2 | Herpes virus (HHV) 8, Blood | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100684-0 | Herpes virus (HHV) 8, Blood | Humaan herpesvirus 8 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 10068-5 | S' wave Amp L-V5 | amplitud de la onda S'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V5 | |||
| 100685-7 | JC virus, Blood | JC-virus DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | |||||
| 100686-5 | JC virus, Spinal fluid | JC-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | |||||
| 100687-3 | JC virus, Urine | JC-virus DNA [logaritmisch aantal/volume] in urine d.m.v. probe-detectie | |||||
| 100688-1 | Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Blood | Parvovirus B19 DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
| 100689-9 | Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Blood | Toxoplasma gondii DNA [logaritmisch aantal/volume] in serum of plasma d.m.v. probe-detectie | ||||
| 100690-7 | Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Spinal fluid | Toxoplasma gondii DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
| 100691-5 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Blood | Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | ||||
| 100692-3 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Spinal fluid | Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | ||||
| 10069-3 | S' wave Amp L-V6 | amplitud de la onda S'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V6 | |||
| 100693-1 | Pneumocystis jiroveci, Respiratory system specimen | Pneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie | |||||
| 100694-9 | SMN1 gene silent carrier analysis, Blood or tissue specimen | Stille drager van SMN1-gen analyse [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100695-6 | Genetic disease analysis overall carrier interpretation, Blood or tissue specimen | ||||||
| 100696-4 | CTNS related multigene analysis, Body Fld+S/P | CTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek | |||||
| 100699-8 | Rifabutin/Ethambutol-Empfindlichkeit | Rifabutin+Ethambutol [Empfindlichkeit] | Susceptibility to Rifabutin+Ethambutol | Rifabutine + ethambutol [gevoeligheid] in isolaat | |||
| 100700-4 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis DNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
| 10070-1 | S' wave dur L-AVF | duración de la onda S'.derivación AVF:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVF | |||
| 100701-2 | Trichomonas vaginalis, Urethra | Trichomonas vaginalis rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | |||||
| 100702-0 | Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urethra | Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie | ||||
| 100703-8 | Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urine | Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie | ||||
| 100704-6 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial vom Gebärmutterhals mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Cervix | Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie | ||||
| 100705-3 | Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Anorectal | Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie | ||||
| 100706-1 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Specimen | Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100707-9 | Polymorphonuclear cells, Peritoneal dialysis fluid | Polymorfonucleaire cellen [aantal/volume] in periteonale dialysevloeistof d.m.v. geautomatiseerde telling | |||||
| 100708-7 | Plasma cells per 100 white blood cells, Synovial fluid | Plasmacellen/100 leukocyten [getalsfractie] in synoviaal vocht | |||||
| 100709-5 | Hepatocellular carcinoma risk | Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score | |||||
| 100710-3 | Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat | Chlamydia trachomatis & Neisseria gonorrhoeae rRNA panel in keel d.m.v. probe-detectie | |||||
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels Immunoassay | Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood | Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay | ||||
| 100712-9 | Brexpiprazol | Brexpiprazole, Blood | Brexpiprazol [massa/volume] in serum of plasma | ||||
| 100713-7 | Cariprazin | Cariprazine, Blood | Cariprazine [massa/volume] in serum of plasma | ||||
| 100714-5 | Guanfacin | Guanfacine, Blood | Guanfacine [massa/volume] in serum of plasma | ||||
| 100715-2 | Prothipendyl | Prothipendyl, Blood | Prothipendyl [massa/volume] in serum of plasma | ||||
| 100716-0 | Prostate specific antigen, Dried blood spot | Prostaatspecifiek Ag [massa/volume] in gedroogde bloedspot | |||||
| 100717-8 | FCGR3A gene.p.Phe176Val, Blood or tissue specimen | FCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 10071-9 | S' wave dur L-AVL | duración de la onda S'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVL | |||
| 10072-7 | S' wave dur L-AVR | duración de la onda S'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. adelantar AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVR | |||
| 100732-7 | Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, Blood | Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum | |||||
| 100733-5 | LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood | Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend | |||||
| 100734-3 | traMADol and Metabolites Panel, Urine | Tramadol & metabolieten panel in urine d.m.v. bevestiging | |||||
| 10073-5 | S' wave dur L-I | duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-I | |||
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells | Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten | |||||
| 100737-6 | Alkaline phosphatase.macromolecular, Blood | Alkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100738-4 | Macromolecular alanine aminotransferase, Blood | Alanine-aminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100739-2 | Macromolecular aspartate aminotransferase, Blood | Aspartaataminotransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 1007-4 | Direkter Coombs Test polyspezifisch | Direkt-Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Presencia o umbral: Ordinal: | Directe antiglobulinetest.polyspecifiek reagens [aanwezigheid] in erytrocyten | DAT Poly-Sp Reag RBC Ql |
| 100740-0 | Amylase.macromolecular, Blood | Amylase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100741-8 | Gamma glutamyl transferase.macromolecular, Blood | Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100742-6 | Lactate dehydrogenase.macromolecular, Blood | Lactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 10074-3 | S' wave dur L-II | duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-II | |||
| 100743-4 | Lipase.macromolecular, Blood | Lipase.macromoleculair [aanwezigheid] in serum of plasma | |||||
| 100744-2 | Alpha-1-acid glycoprotein, Blood | Alfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese | |||||
| 100745-9 | Chloride, Blood | Chloride [mol/volume] in gemengd veneus bloed | |||||
| 100746-7 | Glucose, Blood | Glucose [mol/volume] in gemengd veneus bloed | |||||
| 100747-5 | Legionella serogroup panel, Specimen | Legionella serogroep panel | |||||
| 100748-3 | Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella spp, Specimen | Legionella spp. [aanwezigheid] d.m.v. probe-detectie | ||||
| 100749-1 | Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila serogroup 1, Specimen | Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
| 10075-0 | S' wave dur L-III | duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-III | |||
| 100750-9 | Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila non-serogroup 1, Specimen | Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie | ||||
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel, Blood | Galactose-alfa-1,3-galactose panel in serum of plasma | |||||
| 100752-5 | Exacerbating factors Reported | ||||||
| 100753-3 | Alleviating factors Reported | ||||||
| 100755-8 | Oligoclonal bands, Blood | Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren | |||||
| 100756-6 | Oligoclonal bands, Spinal fluid | Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
| 100757-4 | Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid | Eiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
| 100758-2 | Estimated lung age from clin data | ||||||
| 100759-0 | Inspiratory reserve vol spirometry | ||||||
| 100762-4 | HBA2 gene.c.377T>C, Blood | HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
| 100763-2 | Mycobacterium sp comparative reaction interpretation, Skin | Comparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel) | |||||
| 100764-0 | Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin | Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid | |||||
| 100765-7 | Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot | Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot | |||||
| 100766-5 | Center for Epidemiologic Studies Depression Scale panel [CES-D] | ||||||
| 100767-3 | Bothered by things that are not usually bothersome | ||||||
| 10076-8 | S' wave dur L-V1 | duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V1 | |||
| 100768-1 | Poor appetite | ||||||
| 100769-9 | Unhappy even with help from my family or friends | ||||||
| 100770-7 | Feeling just as good as others | ||||||
| 100771-5 | Trouble focusing | ||||||
| 100772-3 | Feeling depressed | ||||||
| 100773-1 | Feeling everything is too much of an effort | ||||||
| 100774-9 | Feeling hopeful about the future | ||||||
| 100775-6 | Feeling life had been a failure | ||||||
| 10077-6 | S' wave dur L-V2 | duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V2 | |||
| 100776-4 | Feeling fearful | ||||||
| 100777-2 | Restless sleep | ||||||
| 100778-0 | Feeling happy | ||||||
| 100779-8 | Quieter than usual | ||||||
| 100780-6 | Feeling lonely | ||||||
| 100781-4 | People were unfriendly | ||||||
| 100782-2 | Enjoying life | ||||||
| 100783-0 | Crying spells | ||||||
| 10078-4 | S' wave dur L-V3 | duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V3 | |||
| 100784-8 | Feeling sad | ||||||
| 100785-5 | Feeling people dislike me | ||||||
| 100786-3 | Lack of energy | ||||||
| 100787-1 | Total Score CES-D | ||||||
| 100788-9 | Stemphylium botryosum IgG4 antibody | Stemphylium botryosum As.IgG4 [massa/volume] in serum | |||||
| 100789-7 | Rhizopus nigricans IgG4 antibody | Rhizopus nigricans As.IgG4 [massa/volume] in serum | |||||
| 100790-5 | Lepidoglyphus destructor IgG antibody | Lepidoglyphus destructor As.IgG [massa/volume] in serum | |||||
| 100791-3 | Hamster epithelium IgG antibody | Hamsterepitheel As.IgG [massa/volume] in serum | |||||
| 10079-2 | S' wave dur L-V4 | duración de la onda S'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V4 | |||
| 100792-1 | Forsythia allergy test | Forsythia As.IgE [eenheid/volume] in serum | |||||
| 100793-9 | Testosterone, Body fluid | Testosteron [massa/volume] in lichaamsvocht | |||||
| 100794-7 | Follitropin (FSH; Follicle Stimulating Hormone), Body fluid | Follikelstimulerend hormoon [eenheid/volume] in lichaamsvocht | |||||
| 100795-4 | S100 Calcium Binding Protein B, Body fluid | S100 calciumbindend eiwit B [massa/volume] in lichaamsvocht | |||||
| 100796-2 | Thyroglobulin, Body fluid | Thyreoglobuline [massa/volume] in lichaamsvocht | |||||
| 100797-0 | Free testosterone 1st specimen after challenge, Blood | Testosteron.vrij^1ste monster na XXX belasting [massa/volume] in serum | |||||
| 100798-8 | Free testosterone 2nd specimen after challenge, Blood | Testosteron.vrij^2de monster na XXX belasting [massa/volume] in serum | |||||
| 100799-6 | 21-Deoxycortisol 1st specimen after challenge, Blood | 21-deoxycortisol^1ste monster na XXX belasting [massa/volume] in serum | |||||
| 100-8 | Cefoperazon [Empfindlichkeit] mittels Bestimmung der minimalen Hemmkonzentration (MHK) | Susceptibility to Cefoperazone | cefoperazona:susceptibilidad:punto en el tiempo:cepa clínica:ordinal o cuantitativo:concentración inhibitoria mínima | Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) | Cefoperazon [gevoeligheid] in isolaat d.m.v. minimaal inhiberende concentratie | Cefoperazone Islt MIC | |
| 10080-0 | S' wave dur L-V5 | duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V5 | |||
| 100800-2 | 21-Deoxycortisol 2nd specimen after challenge, Blood | 21-deoxycortisol^2de monster na XXX belasting [massa/volume] in serum | |||||
| 100801-0 | 21-Deoxycortisol 3rd specimen after challenge, Blood | 21-deoxycortisol^3de monster na XXX belasting [massa/volume] in serum | |||||
| 100802-8 | 21-Deoxycortisol 4th specimen after challenge, Blood | 21-deoxycortisol^4de monster na XXX belasting [massa/volume] in serum | |||||
| 100803-6 | 21-Deoxycortisol 5th specimen after challenge, Blood | 21-deoxycortisol^5de monster na XXX belasting [massa/volume] in serum | |||||
| 100804-4 | Vasopressin 1st specimen after challenge, Blood | Vasopressine^1ste monster na XXX belasting [mol/volume] in plasma | |||||
| 100805-1 | Vasopressin 2nd specimen after challenge, Blood | Vasopressine^2de monster na XXX belasting [mol/volume] in plasma | |||||
| 100806-9 | Vasopressin 3rd specimen after challenge, Blood | Vasopressine^3de monster na XXX belasting [mol/volume] in plasma | |||||
| 100807-7 | Vasopressin 4th specimen after challenge, Blood | Vasopressine^4de monster na XXX belasting [mol/volume] in plasma | |||||
| 100808-5 | Vasopressin 5th specimen after challenge, Blood | Vasopressine^5de monster na XXX belasting [mol/volume] in plasma | |||||
| 100809-3 | Vasopressin 6th specimen after challenge, Blood | Vasopressine^6de monster na XXX belasting [mol/volume] in plasma | |||||
| 100810-1 | Vasopressin 7th specimen after challenge, Blood | Vasopressine^7de monster na XXX belasting [mol/volume] in plasma | |||||
| 100811-9 | Vasopressin 8th specimen after challenge, Blood | Vasopressine^8ste monster na XXX belasting [mol/volume] in plasma | |||||
| 100812-7 | Vasopressin 9th specimen after challenge, Blood | Vasopressine^9de monster na XXX belasting [mol/volume] in plasma | |||||
| 100813-5 | Vasopressin 10th specimen after challenge, Blood | Vasopressine^10de monster na XXX belasting [mol/volume] in plasma | |||||
| 100814-3 | Vasopressin 11th specimen after challenge, Blood | Vasopressine^11de monster na XXX belasting [mol/volume] in plasma | |||||
| 100815-0 | Vasopressin 12th specimen after challenge, Blood | Vasopressine^12de monster na XXX belasting [mol/volume] in plasma | |||||
| 100816-8 | Glucagon 6th specimen after challenge, Blood | Glucagon^6de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100817-6 | Glucagon 7th specimen after challenge, Blood | Glucagon^7de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 10081-8 | S' wave dur L-V6 | duración de la onda S'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V6 | |||
| 100818-4 | Renin 1st specimen after challenge, Blood | Renine^1ste monster na XXX belasting [massa/volume] in plasma | |||||
| 100819-2 | Renin 2nd specimen after challenge, Blood | Renine^2de monster na XXX belasting [massa/volume] in plasma | |||||
| 1008-2 | Indirekter Coombs Test polyspezifisch | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: | Prueba de antiglobulina indirecta, reactivo específico de poli: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: | Indirecte antiglobulinetest.polyspecifiek reagent [aanwezigheid] in serum of plasma | IAT Poly-Sp Reag SerPl Ql | |
| 100820-0 | Renin 3rd specimen after challenge, Blood | Renine^3de monster na XXX belasting [massa/volume] in plasma | |||||
| 100821-8 | POLST panel | ||||||
| 100822-6 | Cardiopulmonary resuscitation orders | ||||||
| 100823-4 | Initial portable medical treatment orders | ||||||
| 100824-2 | Additional portable medical orders or instructions | ||||||
| 100825-9 | Medically assisted nutrition orders | ||||||
| 10082-6 | ST I-Amp 6ms L-AVF | amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVF | |||
| 100826-7 | Portable medical order &or advance directive review | ||||||
| 100827-5 | Portable medical order discussion participants | ||||||
| 100828-3 | Portable medical order administrative information | ||||||
| 100829-1 | Renin 4th specimen after challenge, Blood | Renine^4de monster na XXX belasting [massa/volume] in plasma | |||||
| 100830-9 | Free alpha subunit 1st specimen after challenge, Blood | Alfa-subeenheid.vrij^1ste monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100831-7 | Free alpha subunit 2nd specimen after challenge, Blood | Alfa-subeenheid.vrij^2de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100832-5 | Free alpha subunit 3rd specimen after challenge, Blood | Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100833-3 | Free alpha subunit 4th specimen after challenge, Blood | Alfa-subeenheid.vrij^4de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 10083-4 | ST I-Amp 6ms L-AVL | amplitud inicial del segmento ST, 6 mseg.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVL | |||
| 100834-1 | Free alpha subunit 5th specimen after challenge, Blood | Alfa-subeenheid.vrij^5de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100835-8 | Free alpha subunit 6th specimen after challenge, Blood | Alfa-subeenheid.vrij^6de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100836-6 | Free alpha subunit 7th specimen after challenge, Blood | Alfa-subeenheid.vrij^7de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100837-4 | Insulin-like growth factor-I 9th specimen after challenge, Blood | Insulin-like growth factor-I^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100838-2 | Testosterone 9th specimen after challenge, Blood | Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma | |||||
| 100839-0 | Vitamin A/Retinol binding protein, Blood | Retinol/retinolbindend eiwit [verhouding] in serum of plasma | |||||
| 100840-8 | IgE, Body fluid | IgE [eenheid/volume] in lichaamsvocht | |||||
| 100841-6 | Zinc finger protein of the cerebellum 4 antibody, Spinal fluid | Zinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot | |||||
| 10084-2 | ST I-Amp 6ms L-AVR | amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVR | |||
| 100842-4 | Nonalcoholic steatohepatitis score, Blood | ||||||
| 100843-2 | Liver fibrosis score, Blood | ||||||
| 100844-0 | Liver fibrosis score, Blood | ||||||
| 100845-7 | Neurofascin155 IgG4 antibody, Blood | Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie | |||||
| 100846-5 | Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100847-3 | Gas and ammonia panel, Blood | Gas en ammoniak panel in arterieel bloed | |||||
| 100848-1 | Cell count and Differential panel, Amniotic fluid | Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling | |||||
| 100849-9 | White blood cell (WBC) count, Amniotic fluid | Leukocyten [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100850-7 | Neutrophils, Amniotic fluid | Neutrofielen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100851-5 | Other cells, Amniotic fluid | Overige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling | |||||
| 100854-9 | Lymphocytes per 100 cells, Blood | Lymfocyten/100 cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay | |||||
| 100855-6 | CD3 cells per 100 cells, Blood | Cellen.CD3/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100856-4 | CD3+CD4+ (T4 Helper) Cells per 100 cells, Blood | Cellen.CD3+CD4+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100857-2 | CD3+CD8+ (T8 Suppressor) Cells per 100 cells, Blood | Cellen.CD3+CD8+/100 cellen [getalsfractie] in mononucleaire cellen in bloed | |||||
| 100858-0 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 10085-9 | ST I-Amp 6ms L-I | amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-I | |||
| 100859-8 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 100860-6 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | ||||
| 100861-4 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100862-2 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100863-0 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nucleokapsid-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | ||||
| 100864-8 | Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia bg gene genotype, Specimen | Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100865-5 | Avian schistosomes, Specimen | Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100866-3 | Febrile antibody profile, Blood | ||||||
| 10086-7 | ST I-Amp 6ms L-II | amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-II | |||
| 100867-1 | Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool | Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | ||||
| 100868-9 | Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium sp 18S-LC2 genotype, Specimen | Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100869-7 | Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik | Cryptosporidium gp60 gene, Specimen | Cryptosporidium gp60-gen [type] d.m.v. moleculair genetisch onderzoek | ||||
| 100870-5 | Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium 18S genotype, Specimen | Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100871-3 | Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia gdh gene genotype, Specimen | Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100872-1 | Bacteria producing polysaccharide from sucrose | Uit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat | |||||
| 100873-9 | Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia tpi gene genotype, Specimen | Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek | ||||
| 100874-7 | Basidiobolus sp, Specimen | Basidiobolus sp. [aanwezigheid] | |||||
| 10087-5 | ST I-Amp 6ms L-III | amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-III | |||
| 10088-3 | ST I-Amp 6ms L-V1 | amplitud inicial del segmento ST, 6 mseg.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | Deprecated ST initial amp 6 ms.lead | |||
| 100885-3 | Parapoxvirus , Specimen | Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100886-1 | Orf virus, Specimen | Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100887-9 | Pseudocowpox virus, Specimen | Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100888-7 | Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade II, Specimen | 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100889-5 | Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade I, Specimen | 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100890-3 | Poxvirus DNA panel | Pokkenvirus DNA panel | |||||
| 10089-1 | ST I-Amp 6ms L-V2 | amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V2 | |||
| 100891-1 | Orthopoxvirus IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgG antibody, Blood | Orthopoxvirus As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100892-9 | Orthopoxvirus IgM-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Orthopoxvirus IgM antibody, Blood | Orthopoxvirus As.IgM [aanwezigheid] in serum of plasma d.m.v. immunoassay | ||||
| 100893-7 | Orthopoxvirus IgG & IgM Ab panel, Blood | Orthopoxvirus IgG & IgM As panel in serum of plasma | |||||
| 100894-5 | Recommended screen freq | ||||||
| 100895-2 | Rickettsia conorii IgG and IgM antibodies, Blood | Rickettsia conorii As.IgG & IgM [interpretatie] in serum | |||||
| 100896-0 | Vasopressin 13th specimen after challenge, Blood | Vasopressine^13de monster na XXX belasting [mol/volume] in plasma | |||||
| 100897-8 | Staphylococcus aureus culture, Specimen | Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek | |||||
| 100898-6 | Lipid panel, Blood | Lipiden panel in serum of plasma | |||||
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen | Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek | |||||
| 1009-0 | Direct antiglobulin test.poly specific reagent, Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: | Prueba de antiglobulina directa, reactivo específico de poli: Eritrocitos : Punto temporal: Concentración arbitraria: Ordinal: | Directe antiglobulinetest.polyspecifiek reagens [eenheid/volume] in erytrocyten | Deprecated DAT Poly-Sp Reag RBC Ql | ||
| 100900-0 | Enterobacteriaceae.carbapenem resistance panel culture, Anal | Enterobacteriaceae.carbapenemresistentie panel in anaal monster d.m.v. organisme-specifieke kweek | |||||
| 100901-8 | Enterobacteriaceae.Carbapenemase-Resistenz-Phänotyp [Nachweis oder Identität] in analem Probenmaterial mittels erregerspezifischer Kultur | Enterobacteriaceae.carbapenemase resistance phenotype culture, Anal | Enterobacteriaceae.carbapenemresistentie fenotype [identificator] in anaal monster d.m.v. organisme-specifieke kweek | ||||
| 100902-6 | Enterobacteriaceae.carbapenemase resistance phenotype.OXA-48 culture, Anal | Enterobacteriaceae.carbapenemresistentie fenotype.OXA-48 [identificator] in anaal monster d.m.v. organisme-specifieke kweek | |||||
| 100903-4 | Yeast & Candida sp identification panel culture, Specimen | Identificatie van gist & Candida sp. panel d.m.v. organisme-specifieke kweek | |||||
| 100904-2 | Urinary tract pathogens panel culture, Urine | Urinewegpathogenen panel in urine d.m.v. kweek | |||||
| 100905-9 | Gram positive bacteria culture | Gram-positieve bacteriën geïdentificeerd [identificator] in isolaat d.m.v. organisme-specifieke kweek | |||||
| 100906-7 | Bacterial culture, Urine | Bacteriën [aantal/volume] in urine d.m.v. kweek | |||||
| 100907-5 | Vancomycin resistant Enterococcus culture, Specimen | Vancomycineresistente Enterococcus [identificator] d.m.v. organisme-specifieke kweek | |||||
| 100908-3 | Pseudomonas aeruginosa culture, Lower respiratory | Pseudomonas aeruginosa [aanwezigheid] in onderste luchtwegen d.m.v. organisme-specifieke kweek | |||||
| 10090-9 | ST I-Amp 6ms L-V3 | amplitud inicial del segmento ST, 6 mseg.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V3 | |||
| 100909-1 | Cronobacter sakazakii [Nachweis] mittels erregerspezifischer Kultur | Cronobacter sakazakii culture, Environmental specimen | Cronobacter sakazakii [aanwezigheid] in milieu d.m.v. organisme-specifieke kweek | ||||
| 100910-9 | Gram negative bacteria.colistin resistant identified in Stool by Organism specific culture | Gram-negatieve bacterie.colistineresistent geïdentificeerd [identificator] in feces d.m.v. organisme-specifieke kweek | |||||
| 100911-7 | Campylobacter sp [Nachweis] in Stuhl mittels erregerspezifischer Kultur | Campylobacter sp culture, Stool | Campylobacter sp. [aanwezigheid] in feces d.m.v. organisme-specifieke kweek | ||||
| 100912-5 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype and Enterococcus species.vancomycin resistant panel | Enterobacteriaceae.ESBL-resistentie fenotype & Enterococcus.vancomycineresistentie panel d.m.v. organisme-specifieke kweek | |||||
| 100913-3 | Staph aureus and MRSA screening panel culture, Specimen | Staphylococcus aureus en MRSA screening panel d.m.v. organisme-specifieke kweek | |||||
| 100914-1 | Protein.abnormal band, Blood | Eiwit.abnormale band [massa/volume] in serum of plasma d.m.v. elektroforese | |||||
| 100915-8 | Burr cells, Body fluid | Burr-cellen [aanwezigheid] in lichaamsvocht d.m.v. microscopie.licht | |||||
| 100916-6 | User satisfaction score [R-Outcomes] | ||||||
| 10091-7 | ST I-Amp 6ms L-V4 | amplitud inicial del segmento ST, 6 mseg.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V4 | |||
| 100917-4 | Product of interest effectiveness | ||||||
| 100918-2 | Product of interest usability | ||||||
| 100919-0 | Access to help with product of interest | ||||||
| 100920-8 | Satisfied with product of interest | ||||||
| 100921-6 | User satisfaction panel [R-Outcomes] | ||||||
| 100922-4 | Privacy panel [R-Outcomes] | ||||||
| 100923-2 | Privacy score | ||||||
| 100924-0 | Safe and secure healthcare data | ||||||
| 10092-5 | ST I-Amp 6ms L-V5 | amplitud inicial del segmento ST, 6 mseg.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V5 | |||
| 100925-7 | Healthcare data exchanged as needed | ||||||
| 100926-5 | Access to review healthcare data | ||||||
| 100927-3 | Satisfied with healthcare data use | ||||||
| 100928-1 | Digital confidence panel [R-Outcomes] | ||||||
| 100929-9 | Digital confidence score [R-Outcomes] | ||||||
| 100930-7 | Digital device use | ||||||
| 100931-5 | Friends use digital devices | ||||||
| 100932-3 | Access to help with digital devices | ||||||
| 10093-3 | ST I-Amp 6ms L-V6 | amplitud inicial del segmento ST, 6 mseg.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms cable V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V6 | |||
| 100933-1 | Confident using digital devices | ||||||
| 100934-9 | Personal safety panel [R-Outcomes] | ||||||
| 100935-6 | Personal safety score [R-Outcomes] | ||||||
| 100936-4 | Feel safe at home | ||||||
| 100937-2 | Feel respected at home | ||||||
| 100938-0 | Feel safe outside home | ||||||
| 100939-8 | Feel respected outside home | ||||||
| 100940-6 | Neighbor relationships panel [R-Outcomes] | ||||||
| 10094-1 | ST Slope L-AVF | desnivel de ST.derivación AVF:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST pendiente plomo AVF:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-AVF | |||
| 100941-4 | Neighbor relationships score [R-Outcomes] | ||||||
| 100942-2 | Neighbors and I know each other | ||||||
| 100943-0 | Neighbors and I trust each other | ||||||
| 100944-8 | Neighbors and I share information | ||||||
| 100945-5 | Neighbors and I help each other | ||||||
| 100946-3 | Loneliness (ONS) score | ||||||
| 100947-1 | Frequency of having no one to talk to | ||||||
| 100948-9 | Frequency of feeling left out | ||||||
| 100949-7 | Frequency of feeling alone | ||||||
| 100950-5 | Frequency of feeling lonely | ||||||
| 100951-3 | Loneliness Office of National Statistics panel | ||||||
| 100952-1 | Product confidence panel [R-Outcomes] | ||||||
| 100953-9 | Product confidence score [R-Outcomes] | ||||||
| 100954-7 | Product of interest use | ||||||
| 100955-4 | Confident using product of interest | ||||||
| 100956-2 | Understand potential benefits of product of interest | ||||||
| 100957-0 | Understand potential problems of product of interest | ||||||
| 10095-8 | ST Slope L-AVL | desnivel del ST.derivación AVL:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST plomo AVL:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-AVL | |||
| 100958-8 | Digital readiness panel [R-Outcomes] | ||||||
| 100959-6 | Digital readiness score [R-Outcomes] | ||||||
| 100960-4 | New ideas are needed in field of work | ||||||
| 100961-2 | Follow new ideas in field of work | ||||||
| 100962-0 | Dengue virus Ab.IgG Panel, Blood | Denguevirus As.IgG panel in serum of plasma of bloed | |||||
| 100963-8 | Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Einheiten/Volumen] in Serum oder Plasma mittels Immunoassay | Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [eenheid/volume] in serum of plasma d.m.v. immunoassay | ||||
| 100964-6 | Dengue-Virus IgG-Antikörper [Nachweis] in Serum, Plasma oder Blut mittels Immunoassay-Schnelltest | Dengue virus IgG antibody, Blood | Denguevirus As.IgG [aanwezigheid] in serum of plasma of bloed d.m.v. immunoassay.sneltest | ||||
| 100965-3 | Dengue-Virus IgG-Antikörper [Interpretation] in Serum, Plasma oder Blut | Dengue virus IgG antibody, Blood | Denguevirus As.IgG [interpretatie] in serum of plasma of bloed | ||||
| 10096-6 | ST Slope L-AVR | desnivel del ST.derivación AVR:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST pendiente plomo AVR:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-AVR | |||
| 100968-7 | Bovine tuberculosis comparative cervical test panel, Skin | Comparatieve cervicale test op boviene tuberculose panel in huid | |||||
| 100969-5 | Pathology report additional specified observation, Specimen | ||||||
| 100970-3 | Portable medical order completion information | ||||||
| 100971-1 | Clin rec panel | ||||||
| 100972-9 | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel, Nose | ||||||
| 100973-7 | Influenza-Virus A RNA [Nachweis] in Probenmaterial von der Nase mittels Nukleinsäureamplifikation mit Detektion ohne Sonde | Influenza A (Flu A), Nose | |||||
| 10097-4 | ST Slope L-I | desnivel del ST.derivación I:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST. Conduzca I:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-I | |||
| 100974-5 | Influenza-Virus B RNA [Nachweis] in Probenmaterial von der Nase mittels Nukleinsäureamplifikation mit Detektion ohne Sonde | Influenza B (Flu B), Nose | |||||
| 100975-2 | Induced abortion method | ||||||
| 100976-0 | Eosinophil derived neurotoxin, Blood | Eosinophil-derived neurotoxin [massa/volume] in serum of plasma | |||||
| 100977-8 | JC virus Ab Index, Blood | JC-virus As index [eenheid/volume] in serum of plasma d.m.v. immunoassay | |||||
| 100978-6 | Thyroxine.free.gestational, Blood | Thyroxine.vrij tijdens zwangerschap [mol/volume] in serum of plasma d.m.v. immunoassay | |||||
| 100979-4 | Atopobium vaginae, Urine | Atopobium vaginae DNA [aanwezigheid] in urine d.m.v. probe-detectie | |||||
| 100980-2 | BK virus, Spinal fluid | BK-virus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | |||||
| 100981-0 | Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Specimen | Parvovirus B19 DNA [logaritmisch aantal/volume] d.m.v. probe-detectie | ||||
| 10098-2 | ST Slope L-II | desnivel del ST.derivación II:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST plomo II:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-II | |||
| 100982-8 | Varicella-Zoster-Virus DNA [log #/Volumen] (Viruslast) in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Varicella zoster virus (VZV; Chickenpox), Specimen | Varicella-zostervirus DNA [logaritmisch aantal/volume] d.m.v. probe-detectie | ||||
| 100983-6 | HIV reverse transcriptase failed codons | HIV reverse transcriptase falende codons [identificator] in isolaat d.m.v. genotypering | |||||
| 100984-4 | HIV 1 group M RNA genotype | HIV 1-groep M RNA genotype [identificator] in isolaat d.m.v. genotypering | |||||
| 100985-1 | HIV protease failed codons | HIV proteases falende codons [identificator] in isolaat d.m.v. genotypering | |||||
| 100986-9 | HIV integrase failed codons | HIV integrase falende codons [identificator] in isolaat d.m.v. genotypering | |||||
| 100987-7 | Lymphocyte t-cell and b-cell and Natural killer subsets panel, Spinal fluid | Lymfocyt T-cel & B-cel & Natural killer subsets panel in liquor cerebrospinalis | |||||
| 100988-5 | Phosphoglucomutase, Fibroblast | Fosfoglucomutase [enzymatische activiteit/volume] in fibroblast | |||||
| 100989-3 | Phosphoglucomutase, White blood cells | Fosfoglucomutase [enzymatische activiteit/volume] in leukocyten | |||||
| 10099-0 | ST Slope L-III | desnivel del ST.derivación III:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST plomo III:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-III | |||
| 100990-1 | Blood group antigens panel, Father Red blood cells | Bloedgroepantigenen panel in erytrocyten^vader | |||||
| 100994-3 | B-cell CD19 and CD20 subsets panel, Blood | B-cel CD19- & CD20-subset panel in bloed d.m.v. flowcytometrie | |||||
| 100995-0 | Laceyella sacchari IgG qualitativ | Laceyella sacchari IgG antibody, Blood | Laceyella sacchari As.IgG [aanwezigheid] in serum | ||||
| 100996-8 | Neurofilament light chain, Spinal fluid | Lichte keten van neurofilament [massa/volume] in liquor cerebrospinalis | |||||
| 100997-6 | Respiratory Allergen Panel, Area 5 | Respiratoire allergenen panel, gebied 5 in serum | |||||
| 100998-4 | Cortisol post dose insulin IV panel, Blood | Cortisol na dosis insuline IV panel in serum of plasma | |||||
| 100999-2 | Somatotropin post dose insulin IV panel, Blood | Somatotropine na dosis insuline IV panel in serum of plasma | |||||
| 101000-8 | Health Info Leader+Champion of Interop | ||||||
| 101001-6 | Chief Architect+Leader of LOINC | ||||||
| 101002-4 | Monkeypox virus sequencing panel, Specimen | 'Mpox'-virus sequencing panel d.m.v. sequencing | |||||
| 101003-2 | Affenpocken-Virus-Klade [Typ] in Probenmaterial mittels Sequenzierung | Monkeypox virus clade, Specimen | 'Mpox'-virus clade [type] d.m.v. sequencing | ||||
| 101004-0 | Affenpocken-Virus-Abstammungslinie [Nachweis] in Probenmaterial mittels Sequenzierung | Monkeypox virus lineage, Specimen | 'Mpox'-virus lineage [type] d.m.v. sequencing | ||||
| 10100-6 | ST Slope L-V1 | desnivel del ST.derivación V1:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST, plomo V1:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V1 | |||
| 10101-4 | ST Slope L-V2 | desnivel del ST.derivación V2:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST, plomo V2:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V2 | |||
| 10102-2 | ST Slope L-V3 | desnivel del ST.derivación V3:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST, plomo V3:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V3 | |||
| 10103-0 | ST Slope L-V4 | desnivel del ST.derivación V4:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST, plomo V4:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V4 | |||
| 10104-8 | ST Slope L-V5 | desnivel del ST.derivación V5:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST, plomo V5:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V5 | |||
| 10105-5 | ST Slope L-V6 | desnivel del ST.derivación V6:índice de voltaje (amperaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Pendiente ST plomo V6:Corazón :Punto temporal:ElpotRat:Cuantitativo:EKG | ST Slope L-V6 | |||
| 101060-2 | An^a antibody, Blood | A kleine n super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101061-0 | Be^a antibody, Blood | B kleine e super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101062-8 | BARC antibody, Blood | BARC As [aanwezigheid] in serum of plasma | |||||
| 10106-3 | ST wave ED L-AVF | desplazamiento de onda ST.final.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de la onda ST, cable final AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-AVF | |||
| 101063-6 | Co3 Ag antibody, Blood | C kleine o3 As [aanwezigheid] in serum of plasma | |||||
| 101064-4 | Co3 Ag antigen, Red blood cells | C kleine o3 Ag [aanwezigheid] in erytrocyten | |||||
| 101065-1 | Co4 antibody, Blood | C kleine o4 As [aanwezigheid] in serum of plasma | |||||
| 101066-9 | Cr^a antibody, Blood | C kleine r super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101067-7 | Cs^b antibody, Blood | C kleine s super kleine b As [aanwezigheid] in serum of plasma | |||||
| 101068-5 | Cs^b antigen, Red blood cells | C kleine s super kleine b Ag [aanwezigheid] in erytrocyten | |||||
| 101069-3 | CE antibody, Blood | ||||||
| 101070-1 | CEAG antibody, Blood | CEAG As [aanwezigheid] in serum of plasma | |||||
| 10107-1 | ST wave ED L-AVL | desplazamiento de onda ST.final.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-AVL | |||
| 101071-9 | CELO antibody, Blood | CELO As [aanwezigheid] in serum of plasma | |||||
| 101072-7 | CENR antibody, Blood | CENR As [aanwezigheid] in serum of plasma | |||||
| 101073-5 | CEST antibody, Blood | CEST As [aanwezigheid] in serum of plasma | |||||
| 101074-3 | CEVF antibody, Blood | CEVF As [aanwezigheid] in serum of plasma | |||||
| 101075-0 | Crawford antibody, Blood | Crawford As [aanwezigheid] in serum of plasma | |||||
| 101076-8 | Dh^a antibody, Blood | D kleine h super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101077-6 | Dr^a antibody, Blood | D kleine r super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101078-4 | Dw antibody, Blood | D kleine w As [aanwezigheid] in serum of plasma | |||||
| 101079-2 | DAK antibody, Blood | DAK As [aanwezigheid] in serum of plasma | |||||
| 1010-8 | E sup(w) antibody, Blood Product Unit | [anticuerpo anti - ] E [mayúscula] W [minúscula] [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal: | E super sub w Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: | E super w As [aanwezigheid] in serum of plasma^bloedproducteenheid | Ew Ac SerPl BPU Ql | ||
| 101080-0 | En^a antibody, Blood | E kleine n super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101081-8 | Es^a antibody, Blood | E kleine s super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101082-6 | Evans antibody, Blood | Evans As [aanwezigheid] in serum of plasma | |||||
| 101083-4 | Fy5 antibody, Blood | F kleine y5 As [aanwezigheid] in serum of plasma | |||||
| 101084-2 | FPTT antibody, Blood | FPTT As [aanwezigheid] in serum of plasma | |||||
| 101085-9 | Ge1 antibody, Blood | G kleine e1 As [aanwezigheid] in serum of plasma | |||||
| 101086-7 | Ge2 antibody, Blood | G kleine e2 As [aanwezigheid] in serum of plasma | |||||
| 101087-5 | Ge2 antigen, Red blood cells | G kleine e2 Ag [aanwezigheid] in erytrocyten | |||||
| 101088-3 | Ge3 antibody, Blood | G kleine e3 As [aanwezigheid] in serum of plasma | |||||
| 10108-9 | ST wave ED L-AVR | desplazamiento de onda ST.final.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST Cable final AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-AVR | |||
| 101089-1 | Ge3 antigen, Red blood cells | G kleine e3 Ag [aanwezigheid] in erytrocyten | |||||
| 101090-9 | Ge4 antibody, Blood | G kleine e4 As [aanwezigheid] in serum of plasma | |||||
| 101091-7 | Hr^s antibody, Blood | H kleine r super kleine s As [aanwezigheid] in serum of plasma | |||||
| 101092-5 | Hr^B antibody, Blood | H kleine r super B As [aanwezigheid] in serum of plasma | |||||
| 101093-3 | Hut antibody, Blood | H kleine ut As [aanwezigheid] in serum of plasma | |||||
| 101094-1 | In^a antibody, Blood | I kleine n super kleine a As [aanwezigheid] in serum of plasma | |||||
| 101095-8 | IFC antibody, Blood | IFC As [aanwezigheid] in serum of plasma | |||||
| 101096-6 | Jo sup(a) antibody, Blood | J klein o super kleine a As [aanwezigheid] in serum of plasma | |||||
| 10109-7 | ST wave ED L-I | desplazamiento de onda ST.final.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de la onda ST, cable final I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-I | |||
| 101097-4 | JAHK antibody, Blood | JAHK As [aanwezigheid] in serum of plasma | |||||
| 101098-2 | JMH antigen, Red blood cells | JMH Ag [aanwezigheid] in erytrocyten | |||||
| 101099-0 | Km antibody, Blood | K kleine m As [aanwezigheid] in serum of plasma | |||||
| 101100-6 | K little u antigen, Red blood cells | K kleine u Ag [aanwezigheid] in erytrocyten | |||||
| 101101-4 | Kx antibody, Blood | K kleine x As [aanwezigheid] in serum of plasma | |||||
| 101102-2 | Kx antigen, Red blood cells | K kleine x Ag [aanwezigheid] in erytrocyten | |||||
| 101103-0 | C^G antibody, Blood | C super G As [aanwezigheid] in serum of plasma | |||||
| 101104-8 | Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.18.11 during assessment period [CMS Assessment] | ||||||
| 10110-5 | ST wave ED L-II | desplazamiento de onda ST.final.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de la onda ST, cable final II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-II | |||
| 101105-5 | MDS v3.0 - RAI v1.18.11 - Nursing home comprehensive (NC) item set during assessment period [CMS Assessment] | ||||||
| 101106-3 | MDS v3.0 - RAI v1.18.11 - Nursing home quarterly (NQ) item set during assessment period [CMS Assessment] | ||||||
| 101107-1 | MDS v3.0 - RAI v1.18.11 - Nursing home discharge (ND) item set during assessment period [CMS Assessment] | ||||||
| 101108-9 | MDS v3.0 - RAI v1.18.11 - Nursing home and Swing bed tracking (NT and ST) item set [CMS Assessment] | ||||||
| 101109-7 | MDS v3.0 - RAI v1.18.11 - Nursing home part A PPS discharge (NPE) item set during assessment period [CMS Assessment] | ||||||
| 101110-5 | MDS v3.0 - RAI v1.18.11 - Nursing home PPS (NP) item set during assessment period [CMS Assessment] | ||||||
| 101111-3 | MDS v3.0 - RAI v1.18.11 - Interim Payment Assessment (IPA) item set during assessment period [CMS Assessment] | ||||||
| 101112-1 | MDS v3.0 - RAI v1.18.11 - Swing bed PPS (SP) item set during assessment period [CMS Assessment] | ||||||
| 10111-3 | ST wave ED L-III | desplazamiento de onda ST.final.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de la onda ST, cable final III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-III | |||
| 101113-9 | MDS v3.0 - RAI v1.18.11 - Swing bed discharge (SD) item set during assessment period [CMS Assessment] | ||||||
| 101114-7 | NCSBN ID | ||||||
| 101115-4 | Leukotriene E4/Creatinine, Urine | Leukotriene E4/creatinine [massaverhouding] in 24-uursurine | |||||
| 101116-2 | THSD7A antigen, Tissue | ||||||
| 101120-4 | Candida glabrata+krusei, Blood | Candida glabrata + krusei DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 10112-1 | ST wave ED L-V1 | desplazamiento de onda ST.final.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V1 | |||
| 101121-2 | Candida albicans+tropicalis, Blood | Candida albicans + tropicalis DNA [aanwezigheid] in bloed d.m.v. probe-detectie | |||||
| 101122-0 | Mephobarbital, Blood | Mefobarbital [massa/volume] in bloed d.m.v. bevestiging | |||||
| 101123-8 | Bakterielle Carbapenem-Resistenz blaIMI-Gen [Nachweis] mittels Molekulargenetik | Bacterial carbapenem resistance blaIMI gene | Bacteriële carbapenemresistentie blaIMI-gen [aanwezigheid] in isolaat of monster d.m.v. moleculair genetisch onderzoek | ||||
| 101124-6 | Bakterielle Carbapenem-Resistenz blaIMI+blaNMC-Gene [Nachweis] mittels Molekulargenetik | Carbapenem resistance blaIMI+blaNMC genes | Bacteriële carbapenemresistentie blaIMI-gen + blaNMC-gen [aanwezigheid] in isolaat of monster d.m.v. moleculair genetisch onderzoek | ||||
| 101125-3 | Bakterielle Carbapenem-Resistenz blaOXA-235-ähnliches Gen [Nachweis] mittels Molekulargenetik | Carbapenem resistance blaOXA-235-like gene | Bacteriële carbapenemresistentie blaOXA-235-achtig gen [aanwezigheid] in isolaat of monster d.m.v. moleculair genetisch onderzoek | ||||
| 101126-1 | Bakterielle Carbapenem-Resistenz blaOXA-24+blaOXA-40-Gene [Nachweis] mittels Molekulargenetik | Carbapenem resistance blaOXA-24+blaOXA-40 gene | Bacteriële carbapenemresistentie blaOXA-24-gen + blaOXA-40-gen [aanwezigheid] in isolaat of monster d.m.v. moleculair genetisch onderzoek | ||||
| 101127-9 | Bakterielle Carbapenem-Resistenz blaSIM-Gen [Nachweis] mittels Molekulargenetik | Carbapenem resistance blaSIM gene | Bacteriële carbapenemresistentie blaSIM-gen [aanwezigheid] in isolaat of monster d.m.v. moleculair genetisch onderzoek | ||||
| 101128-7 | Theoretical limit of detection, Specimen | Theoretische detectielimiet [aantal] d.m.v. berekend | |||||
| 101129-5 | Lab Device | ||||||
| 101130-3 | Mast cells per 100 cells, Bone marrow | Mestcellen/100 cellen [getalsfractie] in beenmerg d.m.v. flowcytometrie | |||||
| 101131-1 | B-cell precursors, Bone marrow | Precursor-B-cel [getalsfractie] in beenmerg d.m.v. flowcytometrie | |||||
| 101132-9 | Glucose post XXX challenge panel, Blood | Glucose na XXX belasting panel in serum of plasma | |||||
| 101137-8 | MNS29, Blood | MNS29 [aanwezigheid] in serum of plasma | |||||
| 101138-6 | ER^a antibody, Blood | ER super kleine a As [aanwezigheid] in serum of plasma | |||||
| 10113-9 | ST wave ED L-V2 | desplazamiento de onda ST.final.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V2 | |||
| 101139-4 | Hro antibody, Blood | H kleine ro As [aanwezigheid] in serum of plasma | |||||
| 101140-2 | Salmonella sp Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Salmonella sp antigen, Stool | Salmonella sp. Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | ||||
| 101142-8 | NAT2 gene allele genotype, Blood or tissue specimen | NAT2-allel [genotype] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 101143-6 | NAT2 gene product metabolic activity interpretation, Blood or tissue specimen | NAT2-gen product metabole activiteit interpretatie [interpretatie] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 101144-4 | Ustekinumab & Ustekinumab Ab panel, Blood | Ustekinumab & ustekinumab As panel in serum of plasma | |||||
| 101145-1 | Ustekinumab trough, Blood | Ustekinumab^dalspiegel [massa/volume] in serum of plasma d.m.v. immunoassay | |||||
| 101146-9 | Monocyte subsets panel, Blood | Monocyten subsets panel in bloed d.m.v. flowcytometrie | |||||
| 10114-7 | ST wave ED L-V3 | desplazamiento de onda ST.final.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V3 | |||
| 101147-7 | Monocytes per 100 white blood cells, Blood | Monocyten/100 leukocyten [getalsfractie] in bloed d.m.v. flowcytometrie | |||||
| 101148-5 | Monocytes.CD14+CD16- 100 Monocytes, Blood | Monocyten.CD14+CD16-/100 monocyten [getalsfractie] in bloed | |||||
| 101149-3 | Borrelien-Antikörper IgM Index | Borrelia burgdorferi IgM-Antikörperindex [Einheiten/Volumen] in Serum und Liquor | Borrelia burgdorferi IgM index, Serum+Cerebrospinal fluid | Borrelia burgdorferi As.IgM-index [eenheid/volume] in serum en liquor cerebrospinalis | |||
| 101150-1 | RV Output Fick | ||||||
| 101151-9 | RV Output Indicator dilution | ||||||
| 101153-5 | Chemokine (C-C Motif) Ligand 14, Urine | Chemokine (C-C motif) ligand 14 [massa/volume] in urine d.m.v. immunoassay | |||||
| 10115-4 | ST wave ED L-V4 | desplazamiento de onda ST.final.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V4 | |||
| 101154-3 | Calprotectin, Blood | Calprotectine [massa/volume] in serum of plasma | |||||
| 101155-0 | Alpha hydroxyetizolam/Creatinine, Urine | ||||||
| 101156-8 | Alpha hydroxyetizolam, Urine | ||||||
| 101157-6 | Flualprazolam/Creatinine, Urine | Flualprazolam/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101158-4 | Flualprazolam, Urine | Flualprazolam [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101159-2 | Flubromazolam/Creatinine, Urine | Flubromazolam/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 1011-6 | E sup(w) antibody, Donor Blood | [anticuerpo anti - ] E [mayúscula] W [minúscula] [Ac]:concentración arbitraria:punto en el tiempo:relación suero/plasma^donante:ordinal: | E super sub w Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: | E super w As [aanwezigheid] in serum of plasma^donor | Ew Ac SerPl Donr Ql | ||
| 101160-0 | Flubromazolam, Urine | Flubromazolam [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101161-8 | 4-Fluorofentanyl/Creatinine, Urine | ||||||
| 10116-2 | ST wave ED L-V5 | desplazamiento de onda ST.final.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V5 | |||
| 101162-6 | 4-Fluorofentanyl, Urine | ||||||
| 101163-4 | Brorphine, Urine | Brorfine [massa/volume] in urine d.m.v. bevestiging | |||||
| 101164-2 | Brorphine/Creatinine, Urine | Brorfine/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101165-9 | Brorphine, Urine | Brorfine [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101166-7 | Metonitazene, Urine | Metonitazeen [massa/volume] in urine d.m.v. bevestiging | |||||
| 101167-5 | Metonitazene/Creatinine, Urine | Metonitazeen/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101168-3 | Metonitazene, Urine | Metonitazeen [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101169-1 | 2-methyl AP-237, Urine | ||||||
| 10117-0 | ST wave ED L-V6 | desplazamiento de onda ST.final.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, cable final V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda ED L-V6 | |||
| 101170-9 | Soluble-Urokinase-Plasminogen-Aktivator-Rezeptor | Soluble urokinase plasminogen activator receptor, Blood | Soluble receptor voor urokinaseplasminogeenactivator [massa/volume] in serum of plasma | ||||
| 101171-7 | 2-methyl AP-237/Creatinine, Urine | ||||||
| 101172-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis panel, Specimen | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis rRNA panel d.m.v. probe-detectie | |||||
| 101173-3 | Melatonin, Saliva | Melatonine [mol/volume] in speeksel | |||||
| 101174-1 | 17-Hydroxyprogesterone, Saliva | 17-hydroxyprogesteron [massa/volume] in speeksel | |||||
| 101175-8 | Free 3-Methoxytyramine/Creatinine, Blood | 3-methoxytyramine.vrij/creatinine [molaire verhouding] in serum of plasma | |||||
| 101176-6 | Free normetanephrine/Creatinine, Blood | Normetanefrine.vrij/creatinine [molaire verhouding] in serum of plasma | |||||
| 101177-4 | Free metanephrine/Creatinine, Blood | Metanefrine.vrij/creatinine [molaire verhouding] in serum of plasma | |||||
| 101178-2 | Pneumocystis jiroveci, Respiratory system specimen | Pneumocystis jiroveci DNA [drempelwaarde nummer] in respiratoir monster d.m.v. probe-detectie | |||||
| 101179-0 | Free light chains, Urine | Immunoglobuline lichte ketens.vrij/totaal eiwit [massafractie] in 24-uursurine | |||||
| 101180-8 | 2-methyl AP-237, Urine | ||||||
| 101181-6 | MDMB-4en-PINACA, Urine | MDMB-4en-PINACA [massa/volume] in urine d.m.v. bevestiging | |||||
| 101182-4 | MDMB-4en-PINACA/Creatinine, Urine | MDMB-4en-PINACA/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101183-2 | MDMB-4en-PINACA, Urine | MDMB-4en-PINACA [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101184-0 | 4F-MDMB-BINACA, Urine | 4F-MDMB-BINACA [massa/volume] in urine d.m.v. bevestiging | |||||
| 101185-7 | 4F-MDMB-BINACA/Creatinine, Urine | 4F-MDMB-BINACA/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101186-5 | 4F-MDMB-BINACA, Urine | 4F-MDMB-BINACA [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101187-3 | ADB-BUTINACA, Urine | ADB-BUTINACA [massa/volume] in urine d.m.v. bevestiging | |||||
| 10118-8 | ST wave MD L-AVF | desplazamiento de onda ST.medio.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, derivación media AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda MD L-AVF | |||
| 101188-1 | ADB-BUTINACA/Creatinine, Urine | ADB-BUTINACA/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101189-9 | ADB-BUTINACA, Urine | ADB-BUTINACA [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101190-7 | 5F-MDMB-PICA, Urine | 5F-MDMB-PICA [massa/volume] in urine d.m.v. bevestiging | |||||
| 101191-5 | 5F-MDMB-PICA/Creatinine, Urine | 5F-MDMB-PICA/creatinine [massaverhouding] in urine d.m.v. bevestiging | |||||
| 101192-3 | 5F-MDMB-PICA, Urine | 5F-MDMB-PICA [aanwezigheid] in urine d.m.v. bevestiging | |||||
| 101193-1 | Sphincter excision plane, Colorectal cancer specimen | ||||||
| 101194-9 | Mesocolic excision plane, Colorectal cancer specimen | ||||||
| 101195-6 | Depth of invasion beyond muscularis propria, Colorectal cancer specimen | ||||||
| 10119-6 | ST wave MD L-AVL | desplazamiento de onda ST.medio.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Desplazamiento de onda ST, derivación media AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST onda MD L-AVL | |||
| 101196-4 | Inflammatory cell infiltrate, Colorectal cancer specimen | ||||||
| 101197-2 | Lymph nodes with metastasis/Lymph nodes examined, Colorectal cancer specimen | ||||||
| 101198-0 | Albumin, Blood | Albumine [massa/volume] in serum of plasma d.m.v. nefelometrie | |||||
| 101199-8 | Protein.monoclonal band 5, Blood | Eiwit.monoklonaal band 5/totaal eiwit [massafractie] in serum of plasma d.m.v. elektroforese | |||||
| 101200-4 | Protein.monoclonal band 6, Blood | Eiwit.monoklonaal band 6/totaal eiwit [massafractie] in serum of plasma d.m.v. elektroforese | |||||
| 101201-2 | Measles virus IgG index, Serum+Cerebrospinal fluid | Mazelenvirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis | |||||
| 101202-0 | Mumps-Virus IgG-Antikörperindex [Einheiten/Volumen] in Serum und Liquor | Mumps virus IgG index, Serum+Cerebrospinal fluid | Bofvirus As.IgG-index [eenheid/volume] in serum en liquor cerebrospinalis |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-ballot2 generated on Thu, Nov 7, 2024 02:22+0000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change